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It is now fi ve years since the World Health Organization (WHO), with the United 
Kingdom’s Department for International Development (DFID) Animal Health 
Programme, launched the fi rst international meeting to consider how to tackle 
a group of ancient, endemic and largely forgotten zoonotic diseases. During 
the course of that meeting – which brought together some 50 researchers, 
public health practitioners and members of international organizations from 
the Americas, Africa and Asia – we realized that these diseases, although 
different in causation, incidence and impact, had much in common.  Woefully 
under-diagnosed, affecting mainly poor people in remote rural or marginalised 
urban and peri-urban communities, usually in low income countries, these 
are diseases of poverty.  By undermining human health at the same time as 
affecting livestock, they impose a dual burden on poor communities.
In 2007, we met again at the International Livestock Research Institute (ILRI) 
under the aegis of WHO and its partners, this time as a much larger group 
focused on Africa and policy issues. Resource constraints and competing human 
and animal health priorities have meant that these diseases are often simply 
forgotten in Africa.
Out of these meetings came a recognition that control of this group of grossly 
neglected diseases is often impeded by the fact that it depends crucially on 
mobilising both the medical and the veterinary sectors. WHO now recognizes 
these diseases as neglected zoonotic diseases (NZDs). Since 2008, NZDs 
have been an integral part of WHO’s Department of Control of Neglected 
Tropical Diseases and feature in its Global Plan to Combat Neglected Tropical 
Diseases 2008–2015. Priority NZDs were also included in the fi rst WHO report 
on neglected tropical diseases: “Working to overcome the global impact of 
neglected tropical diseases” (WHO, 2010).
This third NZDs meeting, brought together an even larger and more diverse 
group than before.  More than 100 participants from Africa, the Middle East, 
the Americas, Asia and Australia, including policy-makers, international 
organizations, researchers and fi eld workers directly involved in disease control 
attended the meeting, as well as a range of observers including a number 
of young researchers representing the next generation of NZD specialists 
sponsored by the European Union.
In this report we have tried to present the various issues, problems and 
challenges that were discussed against the backdrop of the many inspiring 
control programmes that were presented.   Again and again these programmes 
demonstrated how the NZDs are not so much re-emerging as rediscovered 
– once a concerted effort is made to fi nd and treat patients – and how both 
control and prevention rely on involving and inspiring the animal keeping 
communities where they prevail.
The representatives of WHO, DFID-RiU, ICONZ, EU, SOS, TDR and FAO
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Dedication
As this report was being prepared, we learnt with great sadness 
of the passing away of Isabel Minguez-Tudela on Saturday 16 
April, 2011. Despite her illness, Isabel was determined to attend 
this third NZD meeting, having been a staunch advocate of work 
on these diseases for many years. 
Isabel attended the fi rst WHO NZD meeting in 2005 and her 
enthusiasm and institutional support were a major motivating 
factor in the setting up of the subsequent two meetings.  
Many of those working in this fi eld have benefi tted from her 
encouragement and support.
She was born in Spain in 1956.  She studied as a veterinarian and her PhD 
provided important new insights into African Swine Fever. She initially worked 
as a veterinary inspector for the Spanish border control agency.  In 1990 
she joined the European Commission. In 1996 she became senior scientifi c 
offi cer at the Directorate General for Research and Innovation. Since then 
she commissioned and managed a large portfolio of animal health research 
projects.  In her presentation at our meeting, she described with passion 
several important EU projects on neglected zoonoses research that she was 
currently involved with. Isabel has left behind an important legacy of progress 
in the fi eld of animal health research and strong networks among veterinary 
scientists.  She played a vital role in raising the international profi le of the 
neglected zoonotic diseases.
Isabel was also paying special attention to the next generation of zoonoses 
researchers and control offi cers. To that goal she worked very hard in October 
2011, in spite of her ill health, to ensure the participation at this meeting of 
no fewer than 29 mostly young professionals from East African and European 
countries.
She will be remembered for her total dedication to zoonoses research and 
control, a strong determination to move the subject always a step further and 
her unfailing kindness. For many of us, our ongoing work in this fi eld will be 
inspired by her.
In memory of the encouragement, inspiration and kindness she showed to 
so many of us and of all she has done to promote the cause of those suffering 
from, and at risk of contracting NZDs, we dedicate this report to her.
François Meslin
NZD
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Summary
Four main themes emerged from this meeting.
First, under-diagnosis and misdiagnosis are more important issues than 
previously thought. They are crucial to understanding why this cluster of 
diseases is so chronically neglected.  Talk after talk highlighted how it is only 
once investigations start that patients are found. Typically, these patients have 
been treated for another condition, notably malaria, often several times. Many 
NZDs involve severe disability; several are fatal if left untreated. Published 
case histories are necessarily those of people who were diagnosed – the others 
simply silently suffer an untold burden of human misery and ultimately death.   
The cost of misdiagnosis is not only that of untreated patients but also of the 
household and public sector resources wasted and misallocated to the wrong 
diagnosis.  Thus the need to improve diagnostic capacity – by reinforcing both 
human clinical skills and by supplying appropriate and accurate tests – has 
become urgent.
Second, community engagement and hence empowerment is a crucial if 
success is to be achieved.  Because these are diseases of poverty, occurring in 
remote or marginalised communities, the people affected are burdened with 
the many vital activities necessary for survival on a day to day basis.  Despite 
this, once people recognise the signifi cance of these diseases, communities can 
be mobilised to tackle sanitation issues, bring their roaming dogs forward for 
vaccination, consider boiling their milk – simple but effective examples which 
contribute to reducing the burden of NZDs. 
Third, because NZDs are transmitted to people from animals, controlling animal 
reservoirs can be cheap and effective compared with the costs of providing 
care for patients. However, this requires concerted action and communication 
between the veterinary and medical sectors. The higher profi le that these 
diseases have now achieved has led to greater awareness among both sectors, 
but more resources are needed to translate this awareness into action.
Finally, although further public sector involvement is recommended, since 
zoonoses control is a global public good, underfunding must be tackled by all 
means possible. Public-private partnerships have much to offer in this context. 
There is already an impressive track record of drug donations, but the private 
sector can also help fund novel routes for delivery, especially in combating 
the animal reservoir by tackling livestock health and engaging with livestock 
keepers. Unlocking donor funding will depend on successful advocacy, backed 
up by better information on the true burden of these diseases.
At the end of the meeting the participants drafted a comprehensive 
statement. This brought together the strands from the various discussion and 
presentations. The statement acknowledges the achievements made since 2005, 
notes the many constraints and problems that have to be faced when dealing 
with these diseases and makes recommendations towards a road map for NZD 
control in the future. 
On the positive side: the 
past fi ve years have seen 
a growing interest in these 
diseases, their recognition 
by WHO as neglected 
zoonotic diseases, and the 
launching or continuation 
of many successful control 
programmes.
On the negative side: as more 
work has been done on the 
incidence and impact of these 
diseases we have come to 
realise that they are more 
widespread than we thought, 
cause more ill health in 
humans and more losses 
in livestock – and remain 
desperately under-funded.
At the end of the meeting a 
comprehensive statement – 
developing a roadmap for 
NZD prevention and control – 
was produced. 
NZD
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1 Neglected zoonotic diseases: the “poor cousins of the poor cousins” 
The world is familiar with the global threats of zoonotic viral infections, which 
bring fear to populations in both developed and developing countries. The 
outbreaks of BSE (bovine spongiform encephalopathy) and SARS (severe acute 
respiratory syndrome) and of infl uenza pandemics capable of crossing the 
species barrier, are estimated to have cost the global economy at least US$ 
200 billion. Such zoonoses contrast in many ways with the endemic zoonoses 
to which the poorest livestock-dependent populations are exposed. However, 
pandemic threats can be predicted to emerge frequently and unpredictably 
from human contact with animals. Rapid response becomes a prerequisite 
for governments, United Nations agencies, regulatory authorities and the 
pharmaceutical industry, for coordination, virus surveillance and vaccine 
production – a demand originating primarily from the developed world aimed 
at protecting its populations.
However, the poorest people, defi ned as those who live on less than US$ 2 per 
day, are often overlooked when pandemic threats emerge. They are the ones 
subjected to the daily burden of zoonoses, as are their animals on which they 
are often totally dependent for cash, animal protein and as core assets. No 
effective government services are available to support these people’s needs, 
since they are generally not perceived to contribute signifi cantly to the national 
and global economy. Their governments have few resources to allocate to their 
health as the health systems of poor countries function on only a fraction of 
those of developed economies. Until recently, the developed nations’ view of 
the diseases of the developing world was that there are only a limited number 
of communicable diseases of importance. This stemmed from the power of 
advocacy constituencies and also because these diseases were killing, or had 
the potential to kill, large numbers of people annually. Research and control 
of these diseases receive a large majority of the total amount of funding as 
compared with the many other infections that kill, blind, deform and disable 
many more – the “bottom billion” – those who have few resources to access or 
afford “health care.” 
Thus, either within the Millennium Development Goals (MDGs) or when set 
against the “rapid response / early detection” agenda which has come to 
dominate many activities carried out at the animal–human interface, the 
neglected zoonotic diseases (NZDs) are simply left behind. In the context of 
the MDG 6, neglected tropical diseases (NTDs) fall into the category “other 
diseases”, currently a convenient catch-all basket for policy-makers.  Within 
this group, NZDs form a small subgroup that receives less attention and fewer 
resources. Just as the NTDs are the “poor cousins” of health aid, the NZDs have 
become the even poorer “poor cousins of the poor cousins”. 
To reverse this neglect, there are three priorities which need to be addressed:
 • assessing the burden of zoonoses needs to go beyond DALYs  
  (disability-adjusted life-years) to take into account their dual  
  burden on the health of humans and of livestock and thus their  
  total cost to society; 
 • assessing the cost effectiveness of community health care delivery  
  methods for the control of zoonoses;
 • promoting intersectoral collaboration (health, livestock,   
  agriculture, natural resources and wildlife), cross systems policy  
  and prioritization. 
Only 0.6% of international 
global assistance for health 
is devoted to the control of 
Neglected Tropical Diseases. 
The Neglected Zoonotic 
Diseases (NZDs) probably 
have a share of less than 10% 
of that: 0.06% of the total.
David Molyneux
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2 Five years on – taking stock
In September 2005, researchers, policy-makers and people involved in disease 
control met at WHO’s headquarters in Geneva, Switzerland, to consider a 
selection of endemic zoonoses closely associated with poverty. The group 
identifi ed these as a subset of diseases with a signifi cant cumulative health and 
economic burden which was not being addressed properly. Out of that fi rst 
meeting, NZD1, came the concept of neglected zoonoses.  A second meeting, 
NZD2, was held in Nairobi, Kenya, in November 2007, with a focus on Africa 
and on policy makers. Its theme was applying the “One Health” concept to 
achieve integrated control. 
In the fi ve years since the fi rst meeting, the concept of NZDs has been widely 
accepted and the NZDs platform is now well embedded within the NTD 
Department of WHO. During this period progress has been made in a number 
of fi elds.
 • The burden of these diseases is becoming better known. There are 
  now global estimates of DALYs (disability-adjusted life years, 
  which measure the burden of ill health in people) for   
  echinococcosis, zoonotic leishmaniasis, trypanosomiasis and  
  rabies. These take into account estimates of under-reporting.  
  Studies of the economic burden in livestock in some areas, or  
  for particular outbreaks, exist for some diseases, notably   
  cysticercosis, cystic echinococcosis and Rift Valley fever. Work  
  on assessing the burden of bovine tuberculosis, brucellosis,   
  cysticercosis, foodborne trematode infections, toxoplamosis and  
  zoonotic schistosomiasis is in progress. 
 • Subregional, regional and global disease-specifi c networks and  
  public–private partnerships have been established, facilitating the 
  control of diseases such as fascioliasis and zoonotic trypanosomiasis. 
 • Much work has been done on collating information based on  
  which global situation analyses have been undertaken and  
  research priorities identifi ed.
 • A number of fi eld projects to control and study diseases as well as 
  research and development projects have been undertaken,  
  supported by major funding bodies including, among others,   
  DFID, RiU, the European Commission, the Bill & Melinda Gates  
  Foundation, the Wellcome Trust, the NIH Ecology of Infectious  
  Diseases Program, VLIR and DANIDA.
 • For the fi rst time, target dates have been set for eliminating  
  human and dog rabies in Latin America (by 2015) and ASEAN  
  (Association of South East Asian Nations) countries (by 2020).
Proceedings of the WHO/DFID-AHP 
meeting “The control of neglected 
zoonotic diseases: a route to 
poverty alleviation”.
Integrated Control of Neglected
Zoonotic Diseases in Africa
Applying the “One Health” Concept
Report of a Joint 
WHO/EU/ILRI/DBL/FAO/OIE/AU Meeting
 
ILRI Headquarters, Nairobi, 13–15 November 2007
Integrated control of Neglected 
Zoonotic Diseases in Africa: 
“Applying the One health concept”.
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3 What are neglected zoonotic diseases?
he concept of “neglected” zoonotic diseases emerged from a meeting held at 
WHO’s Geneva headquarters in September 2005. The meeting’s focus was the 
ancient endemic zoonoses that have largely been controlled in North America 
and Europe and which have tended to be forgotten or overlooked as interest in 
these regions has shifted to newly emerging zoonoses which have the potential 
for pandemic spread. During the course of this meeting, it became clear that the 
endemic zoonoses have a number of common characteristics.  These distinguish 
them from the emerging zoonoses with the capacity for rapid global spread 
– such as avian infl uenza and from the foodborne zoonoses – associated with 
intensive farming and the global trade in food products  – that are of economic 
and health signifi cance worldwide and are not confi ned to poorer communities.
 
 • NZDs are ancient diseases that have been known since historical  
  times. In many rich countries they have long been successfully  
  controlled or even eliminated. They are not new pathogens,  
  nor have they recently crossed from affecting animal populations  
  to affecting humans.
 • Their transmission depends on long established relationships  
  and interactions between people and domestic animals or  
  nearby wildlife reservoirs. These relationships persist in many  
  parts of the world, although in some more affl uent environments,  
  where animals are more isolated from people or animal husbandry  
  has become more intensive and controlled, conditions no longer  
  facilitate transmission between animals and people to the same  
  extent. 
 • These are mostly endemic diseases; although they can move with  
  their animal reservoir, they mostly do not spread rapidly on a  
  global scale and are often confi ned by ecological boundaries. 
 • These are serious illnesses that often cause permanent disability  
  and, for several diseases if not dealt with early or appropriately,  
  are inevitably fatal. 
1. Massively under-
reported
2. Cause signifi cant 
human morbidity 
and mortality 
3. Impose a dual 
burden on humans 
and animals
4. Are ancient 
diseases, often 
eliminated in 
 wealthy countries
5. Control at source 
when feasible is 
highly cost-effective 
6. Pose no potential 
for global spread
7. Affect poor 
and marginalized 
communities
NEGLECTED
ZOONOTIC
DISEASES  
A ‘tick’ list for defi ning an 
NZD. A NZD is:
 •  a zoonosis
 • an ancient disease 
 • a disease which   
  imposes a dual burden  
  on human and animal  
  health
which is distinguished from 
more high profi le zoonotic 
diseases because it:
 • affects mostly poor and  
  underserved populations 
 • is under-diagnosed and  
  under-reported
 • does not travel far and  
  cross distant boundaries
 • generates signifi cant
  health burden and   
  economic losses
 • control at source when  
  feasible is cost effective
These last fi ve characteristics 
are shared with the other 
Neglected Tropical Diseases 
(NTDs).
Lorenzo Savioli
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 • Cures exist for these diseases – and where patients are found in
  the early stages of the disease, treatment is often relatively   
  inexpensive and successful.
 • Control of these diseases is usually possible.  Often control is  
  best undertaken via the domestic animal reservoir. For some  
  diseases, control at this level is highly cost effective. Control  
  and elimination, however, may require other interventions in  
  humans (using preventive chemotherapy or case management),  
  increased public awareness to reduce contacts between humans  
  and animals and/or modifi cation of the environment to eliminate  
  populations of intermediate or defi nitive hosts. Some of these  
  diseases rank among the cheapest to control in terms of their  
  benefi t to human health. 
 • NZDs are, above all, diseases of poverty. They affect poor and  
  marginalized people in poorer countries who live in close contact  
  with animals, often in unsanitary conditions, where coverage by  
  health services is already inadequate. 
 • These diseases tend to be overlooked by clinicians as well as  
  policy-makers and are hence under-diagnosed and hence under- 
  reported. They often share clinical features, particularly fevers,  
  with other more common diseases or require complex diagnostic  
  tests to confi rm their presence. 
 • There is often a general lack of responsibility for zoonotic
  diseases at provincial, national and regional levels, and a   
  subsequent failure to prioritize their control by human and  
  animal health sectors.
 • Because of under-reporting or lack of public or international  
  interest, the global burden of individual NZDs in terms of DALYs is  
  often either an underestimate, or has never been appropriately  
  calculated.
Finally, one or more of these diseases is found in most poor communities 
where livestock are kept, affecting the health and productivity of livestock 
by causing infertility, death, low milk yields and rendering meat inedible.  
Thus they impose a dual burden on human and animal health in the very 
households and populations least able to cope with such problems
Programmes to control diseases 
like brucellosis were launched 
in Europe decades ago. Maltese 
stamp commemorating the 1964 
anti-brucellosis congress.
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4 Neglected zoonotic diseases: an open-ended list 
In 2005, the fi rst international meeting on neglected zoonoses considered 
seven endemic zoonoses: anthrax, bovine tuberculosis, brucellosis, T. Solium 
cysticercosis/taeniosis, cystic echinococcosis/hydatidosis,human and dog rabies 
and zoonotic human African trypanosomiasis. Since then, as international 
awareness of these conditions has increased and a clearer idea of their 
characteristics has emerged, the list has grown. The map below shows the 
diseases identifi ed as major NZDs by WHO region. These diseases are most 
widespread among poorer populations, but while some are geographically 
restricted others are found in all six WHO regions. As evidenced for the 
African Region, these diseases often overlap at country level. More than 30% 
of African countries have three or more of the fi ve following NZDs (cutaneous 
leishmaniasis, zoonotic trypanosomiasis, echinococcosis, porcine cysticercosis 
and dog rabies) in various combinations.
The list is not exhaustive and it remains open-ended. For example, over the 
past few years, Streptococcus suis has emerged as a signifi cant zoonotic 
disease mostly affecting poor pig farmers in China and other countries of the 
South-East Asia Region. Although not initially considered an NZD, an epidemic-
prone vector-borne zoonosis like Rift Valley fever could be considered part of 
the list because it causes major impacts on the health and livelihoods of small 
livestock producers in the Horn of Africa. Fish-borne liver fl uke infections, 
and the associated negative health impacts, including carcinogenic effects, are 
also important emerging public health problems in East and Southeast Asia.  
There is growing evidence that the zoonotic form of schistosomiasis, caused 
by Schistosoma japonicum, and found in China, Indonesia and the Philippines, 
poses a substantial burden on human health. As information accumulates about 
the common health problems of humans and animals inhabiting marginalized 
livestock-keeping communities, the list of the zoonoses meeting the criteria 
of NZDs may grow. However, operationalizing the NZDs concept may require 
a shorter list of NZDs targeted for control and possible elimination in certain 
geographical and epidemiological settings.
Neglected zoonotic diseases 
have been an integral part 
of WHO’s Department of 
Control of Neglected Tropical 
Diseases since 1 August 2008. 
Control of neglected zoonotic 
diseases is part of the Global 
Plan to combat neglected 
tropical diseases, 2008–2015
Lorenzo Savioli
Of the 12 diseases described 
in detail below, 6 are either 
inevitably fatal or have 
serious forms that lead to 
death if left untreated. 
Bovine tuberculosis
Brucellosis
Cysticercosis 
Echinococcosis
Fascioliasis
Leptospirosis
Rabies
Brucellosis
Echinococcosis
Rabies
Brucellosis
Echinococcosis
Rabies 
Zoonotic cutaneous 
leishmaniasis
Anthrax
Bovine tuberculosis
Brucellosis
Cysticercosis 
Echinococcosis
Rabies
 Rift Valley fever
Zoonotic 
trypanosomiasis
Rabies 
Echinococcosis
Foodborne 
trematodoses
Cysticercosis 
Leptospirosis
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A brief description of each disease follows.
Alveolar echinococcosis(AE) or multilocular echinococcosis
Alveolar echinococcosis, or multilocular echinococcosis, is caused by the 
tapeworm Echinococcosis multilocularis. The natural defi nitive hosts are 
foxes, chiefl y the red fox and arctic fox. The intermediate hosts are wild 
rodents infected by ingestion of the eggs spread in the faeces of infected foxes. 
Domestic dogs and cats may also serve as defi nitive hosts by ingesting infected 
wild rodents.  Humans can become infected when handling dead foxes or 
eating uncooked wild plants contaminated with infected foxes faeces.  Alveolar 
echinococcosis can have serious consequences for human health. Parasitic 
infi ltrative tumour-like lesions can be formed in the liver, lungs and brain and if 
untreated, the outcome is fatal.
The distribution of E. multilocularis is limited to the northern hemisphere. 
In north America, the parasite is present in subarctic regions of Alaska and 
Canada and in a few northern states of the United States. In Europe it is 
spreading in central, eastern and western countries and is endemic in the 
central Asian republics, Afghanistan, Turkey, the Islamic Republic of Iran, the 
Russian Federation, northern Japan, western China and northern United States 
and Canada. A systematic review on the burden of alveolar echinococcosis 
commissioned by WHO indicated that greater than 90% of the global burden of 
this disease is occurring in China.
Anthrax
Anthrax is primarily a disease of herbivores, although all warm-blooded species 
are susceptible to an extent. The causative agent is the spore-forming bacterium 
Bacillus anthracis. The disease reservoir is soil contaminated by spores in 
the recent past or possibly several decades ago. Humans normally acquire 
anthrax either by direct or indirect contact with infected animals or through 
occupational exposure to contaminated animal products. About two-thirds of 
reported cases occur in developing countries. In animals, the disease is almost 
always rapidly fatal. In humans, the disease takes three forms. Inhalation 
anthrax is an occupational disease reported only in industrialised countries 
and acquired by breathing in spores; gastro-intestinal anthrax is acquired from 
eating infected meat from an animal that died of the disease and the cutaneous 
form, which accounts for more than 95% of reported cases in developing 
countries, is acquired through skin lesions.  Although in the West the disease 
incites fear because of its bioterrorist potential, its role in causing illness in poor 
livestock-keeping communities and sudden deaths in their herds and fl ocks is 
largely ignored.
Bovine tuberculosis
In humans, the vast majority of cases of tuberculosis are caused by 
Mycobacterium tuberculosis. However, humans may be infected by a number 
of other tuberculous (TB) bacteria, of which M. bovis, causing so-called bovine 
tuberculosis, is one of the more prevalent and has the widest host range of all 
such bacteria. Tuberculosis caused by M. bovis often occupies sites other than 
the lungs (extra-pulmonary), but in many cases is clinically indistinguishable 
from M. tuberculosis infection. However, patients with M. bovis infection 
frequently fail to respond to the commonly used anti-tuberculosis medicines, 
sometimes resulting in fatalities. Alternative and more expensive medicines are 
often needed to treat patients, increasing the burden on health services. Little 
is known about the proportion M. bovis contributes to the global tuberculosis 
epidemic, but sporadic cases are reported from many African and Asian 
countries; work undertaken in the United Republic of Tanzania indicates 
that this may be a substantial fraction. Bovine tuberculosis appears to be 
increasing at a similar rate to the total number of cases of TB, so that it shares 
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in the HIV/AIDS-linked pandemic. In livestock, particularly cattle, the disease 
causes lowered productivity, but seldom death. Like brucellosis, bovine TB has 
been largely eliminated from herds in the developed world by a test and cull 
programme.  
Brucellosis
Brucellosis, one of the world’s most widespread zoonoses, is caused by bacteria 
of the genus Brucella that primarily affect cattle, sheep, goats and pigs, causing 
abortion, followed by permanently reduced fertility and chronically lowered 
milk yields in affected animals. The infection can be transmitted to humans 
via direct contact with livestock or through drinking unpasteurised milk from 
an infected animal. Symptoms of human infection include recurrent bouts of 
high temperature – hence its other name, “undulant fever” – and its tendency 
to be misdiagnosed as drug-resistant malaria in tropical countries. A chronic 
debilitating disease, brucellosis can cause a variety of other symptoms, 
including joint pain, fatigue and depression. In areas where the disease is 
endemic, there are substantial losses to livestock producers in affected herds or 
regions. In most developed countries, test-and-slaughter programmes, together 
with compensation for farmers and accreditation and fi nancial incentives for 
disease-free herds, have almost eliminated brucellosis in livestock and few 
human cases occur. 
Cystic echinococcosis  (CE) or hydatid disease
Cystic echinococcosis, or hydatid disease, is caused by the larval stage of the 
tapeworm Echinococcus granulosus. Its natural cycle is as a cyst in sheep and 
as a tapeworm in dogs which feed on infected sheep meat and in turn shed eggs 
in their faeces, which are then ingested by sheep.  Humans become infected by 
ingesting food or drink contaminated with faecal material containing tapeworm 
eggs evacuated by infected carnivores, or when handling or petting infected 
dogs. Cysts often occur in the liver, grow slowly over time and can become 
very large, with diameters of 20–40 cm.  The cure is usually surgery, which is 
both risky and expensive.  Hydatid disease occurs worldwide in communities 
where sheep are reared together with dogs. Control is through deworming of 
dogs and preventing them from eating undercooked sheep meat, especially 
offal, as well as through abattoir control and health education. Hydatid disease 
causes serious human suffering and considerable losses in agricultural and 
human productivity. Transmission is facilitated by a general lack of awareness 
of transmission factors and prevention measures among the population at risk, 
an abundance of stray dogs, poor meat inspection practices in abattoirs, and 
improper disposal of offal and home slaughtering practices.
Cysticercosis and neurocysticercosis (NCC)
Cysticercosis is emerging as a serious problem of public health and agriculture 
in many poorer countries of Latin America, Africa and Asia. Humans acquire 
Taenia solium tapeworms when eating raw or undercooked pork meat infested 
with cysticerci, the larval form of the tapeworm, which develop in the human 
intestine where they establish and become adult tapeworms which can grow 
to more than 3 metres long. The adult worms shed eggs in human faeces, 
which may in turn infect the same or other humans as well as pigs, by direct 
contact with tapeworm carriers or by indirect contamination of water or food. 
The disease is thus strongly associated with keeping pigs in conditions of poor 
hygiene. Ingested eggs result in larval worms that migrate to different parts 
of the human and pig body and form cysts (cysticercosis). A principle site of 
migration in humans is the central nervous system. Human neurocysticercosis, 
which occurs when the cysts develop in the brain, is considered to be the most 
common parasitic infection of the brain and the most frequent preventable 
cause of epilepsy in the developing world. A WHO review of studies reporting 
the frequency of neurocysticercosis worldwide estimated the proportion of 
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neurocysticercosis among people with epilepsy of all ages to be almost 30%.. 
WHO estimates that 10 million of these people with epilepsy live in Africa.
Fascioliasis
Fascioliasis is caused by two agents: Fasciola hepatica and Fasciola gigantica. 
Fasciola hepatica is found in almost all temperate regions where sheep and 
other ruminants are raised. Fasciola gigantica occurs mainly in tropical areas 
such as Africa, south and south-east Asia, southern Europe, Hawaii and in the 
former USSR.
The eggs are excreted with the faeces of humans and other fi nal hosts. They 
penetrate snails in which they develop into cercariae. The cercariae leave the 
snail and develop into metacercariae. The defi nitive hosts become infected by 
ingesting metacercariae along with plants or water. The defi nitive hosts of F. 
gigantica are cattle, domestic buffalos, goats, zebras and sheep. The defi nitive 
hosts of F. hepatica are sheep, cattle and domestic buffalos. Humans can also 
serve as (accidental) defi nitive hosts of the two parasites. Human outbreaks 
have been recorded, mostly related to consuming watercress; recently foci 
with human-to-human transmission in South America have been discovered. 
As with the other NZDs, the extent of the problem often only becomes evident 
when studies are undertaken.  Symptoms in humans include abdominal pain, 
diarrhoea, fever, and chronic infl ammation and obstruction of the bile duct.
Leishmaniasis
Leishmaniasis is caused by several species of the genus Leishmania found 
in many areas of the world, particularly in Africa, Latin America, south 
and central Asia, the Mediterranean basin and the Middle East. Of the 
15 Leishmania species, 13 can be transmitted to humans via animals. 
Transmission of the parasite to humans is usually from an animal reservoir 
harbouring the parasite (small rodents, dogs) through the bites of infected 
female phlebotomine sandfl ies. The disease has a wide range of clinical 
symptoms, which may be cutaneous, mucocutaneous or visceral. Cutaneous 
leishmaniasis is the most common form. Visceral leishmaniasis, the most 
severe form, affects the vital organs and is inevitably fatal if left untreated. 
Leishmaniasis is a poverty-related disease. It affects the poorest of the poor 
and is associated with malnutrition, displacement, poor housing, illiteracy, 
gender discrimination, weakness of the immune system and lack of resources. 
Leishmaniasis is also linked to environmental changes, such as deforestation, 
building of dams, new irrigation schemes and urbanization, and the 
accompanying migration of non-immune people to endemic areas.
In its more severe forms, leishmaniasis causes serious disfi gurement as well 
as death. WHO estimates the global prevalence to be approximately 12 million 
cases, with annual mortality of about 60 000. The size of the population at risk 
is about 350 million. 
Leptospirosis
Leptospirosis is an infection of rodents and other wild and domesticated 
species. Rodents are implicated most often in human cases. The infection in 
humans is contracted through skin abrasions and the mucosa of the nose, 
mouth and eyes. Exposure through water contaminated with urine from 
infected animals is the most common route of infection. High risk groups are 
outdoor and agricultural workers as well as urban slum dwellers living in 
poor accommodation with inadequate street drainage and alongside abundant 
rodent populations. The number of cases may peak during the rainy season and 
can even reach epidemic proportions during fl oods.
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Very little is known about the true incidence of leptospirosis. The disease 
is underreported for many reasons, including diffi culty in distinguishing 
clinical signs from those of other endemic diseases and a lack of appropriate 
diagnostic laboratory services. Leptospirosis presents with a wide variety of 
clinical manifestations and can be fatal, but if detected early, the disease can be 
successfully treated with antibiotics.
Prevention strategies for human leptospirosis include wearing protective 
clothing for people at occupational risk and avoiding swimming in water that 
may be contaminated. Control of the disease in animals depends on the type of 
Leptospira detected and animal species affected, but may be controlled either 
by vaccination or rodent control, or a combination of these strategies.
Rabies
Rabies is probably the most notorious zoonotic infection.  It is caused by a 
virus that usually enters the body through a bite or skin lesion and migrates 
to the brain. Its dramatic symptoms in animals and humans and inevitably 
fatal outcome in untreated patients, have made it by far the most feared of the 
zoonoses. Perhaps most importantly, rabies is entirely preventable, for which 
purpose a range of highly effective biologicals has been available for decades. 
From the public health perspective, vaccinating dogs remains the single 
most effective measure for preventing human rabies. Wildlife species such as 
red foxes and raccoon dogs can also be vaccinated, mostly to prevent their 
transmitting rabies to humans and to domestic animals. In addition vaccination 
may also be used, after careful evaluation, in some endangered species whose 
survival is further put at risk by the presence of rabies in these populations 
(e.g Ethiopian wolves). Various types of post-exposure treatment/prophylaxis 
exist but are often unavailable in isolated rural areas or too expensive for 
governments or individuals to afford. In some areas, signifi cant losses to 
livestock, especially cattle, have been recorded. More than 99% of all human 
deaths from rabies occur in the developing world, and between 30% and 50% 
of these are children, with domestic dogs the source of the vast majority of 
human cases.  Despite being one of the oldest diseases known to humans and 
the existence of highly effective dog vaccines and post-exposure treatments for 
people, it is estimated that some 55 000 people a year suffer a dreadful death 
from this disease.
Rift Valley fever (RVF)
Rift Valley fever is caused by a virus that was fi rst identifi ed in Kenya in 1931, 
from where its name originates. Among animals, the RVF virus is spread 
primarily by the bites of infected mosquitoes, which can acquire the virus from 
feeding on infected animals. Humans are usually infected by direct or indirect 
contact with the blood or organs of infected animals, although they can also be 
infected by mosquitoes and other biting fl ies.
 
Most human cases are thought to be relatively mild and are most often 
unreported. Those infected either experience no detectable symptoms or 
develop a mild form of the disease characterized by a feverish syndrome with 
sudden onset of fl u-like fever, muscle pain, joint pain and headache. However, 
a small percentage of patients develop a much more severe form of the disease. 
The haemorrhagic fever form (less than 1% of cases). is usually fatal, as 
witnessed in recent outbreaks.
For livestock keepers, the disease is of major importance: primarily because 
of the severe losses caused by abortion and death in their animals but also 
because of the movement and marketing controls that are imposed when it 
occurs. Sheep appear to be more susceptible than cattle or camels; the rate of 
abortion in infected ewes is nearly 100%.
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In 2000, cases of Rift Valley fever were confi rmed in Saudi Arabia and Yemen, 
marking the fi rst reported occurrence of the disease outside the African 
continent and raising concerns that it could extend to other parts of Asia and to 
Europe. Outbreaks are closely associated with periods of above-average rainfall. 
Forecasting can predict climatic conditions that are frequently associated with 
an increased risk of outbreaks, and may improve disease control. Livestock can 
be vaccinated against the disease before an outbreak.
Zoonotic Human African trypanosomiasis (HAT) or sleeping sickness
Unlike the other NZDs listed here, whose distribution is worldwide, human 
African trypanosomiasis, or sleeping sickness, is limited to the African 
continent where its insect vector, the tsetse fl y, is found. There are two forms 
of sleeping sickness. The chronic gambiense form is found in West and Central 
Africa and, although infected animals can be found, the disease is maintained 
by transmission between the insect vector and humans.  However, the 
animal reservoir is important in the acute rhodesiense form found in Eastern 
and Southern Africa. Left untreated, the disease is always fatal in humans; 
devastating epidemics have occurred during the past century. Treatment is 
expensive, normally ranging from US$ 150 to UD$ 800 per patient; during the 
later stages of the disease the drugs used for treating the rhodesiense form can 
themselves lead to the deaths of some 5% of patients. Control is via the vector 
and the animal reservoirs. For rhodesiense, the key to preventing the disease 
in humans in most areas is by (i) treating the cattle reservoir using medicines 
and (ii) implementing appropriate vector control measures, many of which can 
be undertaken by farmers themselves. Both cattle treatment and vector control 
confer substantial benefi ts to livestock productivity by controlling the animal 
forms of the disease.
These summaries have been 
compiled from materials 
on the WHO web site and 
summaries submitted by 
scientifi c experts, notably 
those who attended the three 
meetings on NZDs. For further 
information, please consult 
the references listed at the 
end of this report and visit 
the WHO zoonoses web site: 
http://www.who.int/topics/
zoonoses/en/ and individual 
health topics on: http://www.
who.int/topics/en/
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5 What interventions are available ?
A characteristic of the NZDs 
is the range of interventions 
available for the control of 
each disease.  All need to 
be mobilised for effective 
control. However, the most 
cost-effective one is usually 
to control and eliminate, 
if feasible, the disease ‘at 
source’ that is in its domestic 
animal reservoir. 
There is a need for a closer 
relationship between 
the research and control 
community, for the the NZD 
and NTD communities and 
public health to work closely 
together – we should aim to 
have to have a synergistic 
approach and effective 
coordination. 
Chioma Amajoh
In examining control 
programmes we need to be 
aware of the engagement of 
the Ministry of Education 
and involvement of schools.  
Children are central in 
several interventions 
and their role should be 
acknowledged.
Charles Waiswa
PUBLIC HEALTH/ HUMAN 
INTERVENTIONS
 
PREVENTIVE CHEMOTHERAPY
Taeniasis
Fascioliasis
PREVENTIVE IMMUNIZATION
Rabies
(Anthrax, Leptospirosis)
CLINICAL MANAGEMENT 
All NZDs
AVOIDING RISKY BEHAVIOUR
All NZDs
VETERINARY PUBLIC HEALTH/
ANIMAL INTERVENTIONS 
TREATMENT
Cysticercosis
Echinococcosis
Fascioliasis
Trypanosomiasis
PREVENTIVE IMMUNIZATION
Rabies
Anthrax
RVF
Leptospirosis
HOST CONTROL/POPULATION MANAGEMENT
Rodents (leishmaniasis, leptospirosis)
dogs (rabies)
Slaughter of reactors (bovine TB, brucellosis) 
EFFECTIVE MEAT INSPECTIONS
Cysticercosis
Echinococcosis
VECTOR CONTROL
 
Tsetse fl ies (Trypanosomiasis)
Sandfl ies (leishmaniasis)
Snails (Fascioliasis) 
Aedes mosquitoes (RVF)
ENVIRONMENTAL INTERVENTIONS 
IMPROVING ENVIRONMENTAL SANITATION
Stormwater drainage (leptospirosis)
Land drainage (Fascioliasis) 
Community-led total sanitation (cysticercosis)
IMPROVING HUSBANDRY PRACTICES
All NZDs 
UPGRADING ABATTOIRS AND MEAT INSPECTION 
 most NZDs such as 
Echinococcosis, cysticercosis, bovine TB 
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6 Under-diagnosed and misdiagnosed 
For individuals suffering from a neglected zoonotic disease, obtaining health 
care can be a prolonged and expensive process and for many it is doomed to 
failure.  A number of speakers catalogued the problems encountered by people 
in this situation.  As interest in the NZDs grows, more published studies are 
becoming available which include interviews with patients eventually diagnosed 
with a zoonosis about their experiences on the way to obtaining that diagnosis. 
Hospitalized patients receiving treatment for acute sleeping sickness (zoonotic 
human African trypanosomiasis) in Kenya were interviewed (Bukachi et al. 
2009). Their tales make harrowing reading. At best, individuals are thought 
to be possessed by evil spirits: “the traditional healer cut my body and applied 
herbs to cure this strange illness”. As the disease progresses, and repeated 
attempts at curing it fail, individuals are often thought to have HIV/AIDS: 
“my husband also refused to take me to hospital, saying he had spent too 
much money on me and maybe I had contracted HIV”. Successful diagnosis 
can be a random piece of good luck: “a neighbour came across a screening 
team for human African trypanosomiasis and described my symptoms to its 
members”. The 203 patients in this study tried nearly 700 other options to get 
better, and were treated for malaria nearly 600 times.  Other studies paint a 
similar picture.  In Uganda (Odiit et al. 2004), fewer than a quarter of patients 
interviewed were referred for testing for human African trypanosomiasis by 
the health service – most were through neighbours or their own efforts; 67% 
thought they had malaria and 16% thought it was AIDS.  In the United Republic 
of Tanzania, Sindato et al. (2008), tell of the long search for effective treatment 
pursued by a Tanzanian worker from Serengeti National Park. He made six 
visits to dispensaries and hospitals, was treated for malaria eight times, tested 
for HIV/AIDs, treated for meningitis and even diagnosed with “severe sleep 
disorder”. These stories all relate to individuals suffering from the classic 
symptoms of a disease that has long been known to occur in these areas.  
Furthermore, they are the ‘lucky’ ones, the ones who were found and treated.   
Others would simply have died and their deaths been attributed to another 
cause.
A similar story is told for brucellosis. “The majority of brucellosis cases 
presented to hospital with a long history of symptoms. Some 
of the cases had been to hospital several times and had received treatment 
for other diseases such as malaria before being diagnosed as suffering from 
brucellosis”, (Kunda et al., 2007). Nearly half had false negative diagnoses and 
been treated for other diseases.  Because the disease starts with symptoms that 
patients do not consider serious, many delay visiting the health services. The 
cases analysed in this study were detected from among febrile patients with 
joint pain found in the hospital. For those brucellosis patients not enrolled in 
the study and who did not go to that particular hospital, whether their illness 
was correctly diagnosis and proper reatment provided remains unknown.
The other side of these tales of prolonged, painful and expensive searches for a 
correct diagnosis and treatment for a neglected zoonosis is the over-diagnosis 
of common conditions. In much of the tropics, and particularly in sub-Saharan 
Africa, this is most often malaria. The case histories in the previous chapter 
A long, painful path is 
trodden while searching for 
the right treatment – and 
the stories we hear are 
inevitably… the success 
stories. It is likely that many, 
if not most sufferers don’t 
succeed in their quest for 
treatment and for some NZDs 
this leads to their death. 
The more isolated their 
community, the more meagre 
their family’s resources, the 
more likely this becomes. 
“My extended family deserted 
me and I was  labelled a mad 
man. Even my community 
deserted me and stayed 
away, saying I was bewitched 
and had brought evil sprits to 
our home.”
Bukachi et al., 2009
The high opportunity cost 
of health-care seeking was 
confi rmed by the facts that 
people with livestock to 
look after were signifi cantly 
more likely to delay seeking 
treatment, as were people 
living further away from 
hospital.
Kunda et al. 2007
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almost all included several treatments for malaria. In some cases, the patients’ 
blood samples tested positive for malaria, although it was not the main cause 
of their illness. In other cases, it was simply the easy and obvious diagnosis.  
Furthermore, in many situations, patients self-medicate or treat their sick 
children for malaria as soon as they detect a fever. In Africa, it is estimated that 
70% of patients with fever initially buy over-the-counter malaria remedies or 
use traditional medicines for malaria (Amexo et al., 2004). 
In recent years interest in the over-diagnosis of malaria has grown. With the 
introduction of the artemisinin-based treatments, medication for malaria has 
become more expensive and over-diagnosis is thus increasingly costly.  An 
analysis of 24 papers spanning four continents by Amexo et al. (2004), found 
an average rate of over-diagnosis rate of malaria of 61% (range, 28% to 96%).  
More recent studies confi rm this: in Sudan, A-Elgayoum et al. (2009) estimated 
a false-positivity rate for malaria of 76% and in Uganda, Nankabirwa et al. 
(2009) obtained an average over-diagnosis rate for routine malaria diagnosis 
of 69%. The studies show errors in clinical diagnosis and in interpreting 
microscopy results, contributing to a substantial over-diagnosis of malaria. For 
the control of NZDs this is highly signifi cant, as over-diagnosis of more common 
infections plays an important role in NZD under-diagnosis.  For individual 
patients with NZDs this exacerbates the diffi culties they encounter when 
they seek treatment for their condition.  At the health sector and donor level, 
misdiagnosis can ultimately lead to misallocation of resources for health care 
and disease control.
 
One of the main reasons why 
NZDs are under-diagnosed 
is because they are masked 
by other more common 
infections. NZDs are often 
more focalised, and less well 
known. 
“Current recommendations 
and associated clinical 
practices result in massive 
malaria over-diagnosis 
across all age groups and 
transmission areas in 
Uganda.”
Nankabirwa et al., 2009
“The effect of malaria 
misdiagnosis falls most 
heavily on the poor and 
vulnerable who are least able 
to withstand unnecessary 
prolonged ill-health with 
subsequent missed earning 
opportunities and repeated 
visits to health facilities.” 
Amexo et al., 2004
Increasing people’s awareness of less well known diseases: echinococcosis posters in Ganzi 
hospital, Sichuan Province, China.
©
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7 Improving the clinical diagnosis of neglected zoonotic diseases: an urgent need
The case histories and studies presented in the previous chapter demonstrate 
that for many patients with NZDs, obtaining appropriate treatment is a diffi cult 
process and many are initially wrongly treated for other, more common, 
conditions.    
A study in the United Republic of Tanzania specifi cally considered zoonotic 
diseases (Kunda et al., 2008). Medical practitioners, in selected health facilities 
within urban and rural settings, were asked questions about the modes of 
transmission, the clinical features and how to diagnose six zoonoses (anthrax, 
rabies, brucellosis, trypanosomiasis, echinococcosis and bovine tuberculosis). 
The results showed 40% of answers by rural practitioners and 31% of those by 
urban practitioners to be wrong.    
During the fi rst NZD meeting in 2005, the need for better diagnostic tests 
and kits for NZDs was identifi ed as an important constraint. From the studies 
and discussions at the third meeting in 2010, it is clear that it is at least as 
important that the “front line” of health services – the medical offi cers, clinical 
offi cers and other medical workers who are based in rural locations or tend 
to marginalized urban populations who are in contact with animals and at 
risk of NZDs – receive better training in recognizing the zoonotic diseases they 
are likely to encounter. Medical services in many of the countries where NZDs 
are endemic are under-resourced; staff are often transferred to other areas 
just as they are becoming familiar with local health problems, and most have 
enormous workloads. However, the large-scale programmes described during 
this meeting (for example fascioliasis and rabies in China, Peru and Viet Nam) 
have been successful in motivating and creating awareness of NZDs at the level 
of local medical services. This has played a crucial role in their success.
“Increased awareness of 
diseases among health 
workers and the community
is still the most important 
area in disease control… 
Before more weight is put 
on increasing the diagnostic 
capacity of diseases, efforts 
should be made to equip the
practitioners and the general 
community with adequate 
knowledge of zoonoses”
Kunda et al., 2008
Guidelines for the diagnosis and 
treatment of fascioliasis: in Viet Nam 
developed by NIMPE and approved by the 
Ministry of Health in 2006; distributed to 
province and district levels, enabling local 
doctors to diagnose and treat cases.
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8 Disentangling the DALYs: investigating under-reporting
The complicated health-care seeking paths followed by people with an NZD 
and the tendency for these diseases to be misdiagnosed, reinforces the need to 
assess their real burden to humans.
A fi rst step is to gain some idea of what the real incidence or prevalence is. The 
presentations and discussions during the meeting highlighted the three main 
approaches that are being applied in various contexts.
The NZDs’ DALYs need to 
be reclaimed from the other 
diseases to which they have 
been wrongly attributed. 
In Malawi post-mortems 
revealed that a signifi cant 
proportion of children who 
had been diagnosed as having 
cerebral malaria actually 
died of rabies. 
Mallewa et al., 2007
Studies of high risk groups 
thus reveal an avalanche of 
information on undiagnosed 
NZDs. Modelling under-
reporting only serves to 
confi rm this. 
Modelling indicates under-
reporting rates of 40 - 50% 
for the acute zoonotic form 
of sleeping sickness (human 
African trypanosomiasis) are 
not reported, and 90 – 95% 
of deaths are unreported. For 
rabies in the United Republic 
of Tanzania, up to 99% of 
human cases are likely not to 
be reported. For brucellosis 
in Africa the under-reporting 
rate is probably even higher 
than that, since almost all 
diagnosed cases are a result 
of special studies on the 
disease. 
Investigating high risk groups has been the most dramatic, in releasing a 
mass of information pointing to high levels of unreported illness.  
Perhaps the most disturbing account heard during the meeting came from the 
study by Mallewa et al. 2007, where some 800 seriously ill children whose 
illnesses apparently involved central nervous system infection were studied. 
Ultimately, 133 died of the illness with ten (7.5%) of those having been identifi ed 
as suffering from rabies on clinical signs and history of exposure. Consent to 
perform post-mortem on all these children was requested from their families 
and eventually obtained from only 29 of them. Out of those who underwent 
post mortem 4 new rabies cases were diagnosed in the laboratory. A total of 
14 rabies deaths (10.5 %)  was therefore confi rmed among the 133 deaths. 
The authors conclude: “Rabies is an important cause of death in children in 
Malawi, including some for whom cerebral malaria had been diagnosed. Rabies 
virus should be included in the list of pathogens to consider before diagnosing 
cerebral malaria.”
In regions where brucellosis is known to be present, simply testing patients 
with fever repeatedly reveals the presence of brucellosis, as reported by Kunda 
et al. (2007). Investigating over-diagnosis of malaria in Ethiopia, Animut et al. 
(2007) note that 2.6% of febrile illnesses were brucellosis, rising to 6.3% in one 
district.  The effect is even more marked if a recognised very high risk group, 
butchers and abattoir workers, are studied. In Nigeria, studies consistently 
fi nd high rates of brucellosis seropositivity among butchers, ranging from 30% 
to 60%.  In Pakistan, Muktar and Kokab (2008) found an average prevalence 
of 22%. When interviewed, affected individuals had usually long suffered the 
classic symptoms of brucellosis but had never received appropriate treatment. 
Surveys of leptospirosis, which was thought to be relatively uncommon, have 
shown very high rates of exposure, for example, 16% in gold-panning villages 
in Gabon (Bertherat et al., 1999); while the actual incidence of the disease in 
Hawaii (USA) is double the reported rate.   
Model 
key 
parameters
Survey 
a 
population
Investigate 
high risk 
groups
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One approach to assessing the true incidence of NZDs in areas where there is a 
high level of under-reporting is mathematical modelling, using an appropriate 
indicator.  A number of studies of this nature were discussed during the 
meeting.
For rabies, two key studies were cited. Investigating the situation in the United 
Republic of Tanzania, Cleaveland et al. (2002) used dog bite injuries as a basis 
for modelling rabies incidence. Using this model, they estimated that while the 
number of human deaths from rabies reported annually was 10, the overall 
total could be as high as 1500.  This type of modelling approach was extended, 
alongside other data, by Knobel et al. (2005) to estimate the deaths and DALY 
burden from rabies in Africa and Asia; the resulting fi gures of 55 000 deaths 
annually and 1.7 million DALYs have now become widely accepted.
For zoonotic sleeping sickness (T. b. Rhodesiense human African 
trypanosomiasis) an under-reporting model has also been developed based 
on the duration of each of the two distinct phases of the disease (pre- and 
post- central nervous system involvement) and on the proportion of diagnosed 
patients found to be in each stage of the disease. The model calculated that in 
Uganda 40% of patients and in the United Republic of Tanzania 50% of cases 
were going un-reported (Odiit et al., 2005, Fèvre et al., 2009, Matemba et al., 
2010). 
For brucellosis, there has been little modelling, although Makita et al. (2010) 
investigated the contamination of milk in urban Kampala and, from this, 
modelled an annual incidence rate of 5.8 per 10 000 people.
Finally, obtaining true estimates of incidence or prevalence requires a 
systematic population survey.  A number of presentations discussed systematic 
surveys and campaigns and, in each case, a substantial hidden disease burden 
was revealed.
Disease Misdiagnosed as…
Brucellosis Malaria, fl u
Zoonotic sleeping sickness Malaria, AIDS, meningitis, madness 
Hydatid disease  Cirrhosis, liver cancer, amoebiasis
Rabies Cerebral malaria, madness
Rift Valley fever Malaria
Neurocysticercosis Other causes of epilepsy, including   
 witchcraft and spirit possession
Bovine tuberculosis Human tuberculosis, malaria
Often the “discovery” that 
a lot of people are suffering 
from an endemic disease is 
mistakenly described as that 
disease “emerging”or 
“re-emerging”. In fact what 
has happened is that people 
are at last being correctly 
diagnosed and treated for a 
hidden, neglected, disease.
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9 Quantifying the “double whammy”: a must for effective advocacy
Zoonotic diseases impose a “double whammy” on society by affecting both 
people and animals. Effective control programmes thus make it possible to 
reap a dual harvest from both better human health and improved livestock 
productivity. Successful advocacy must combine improved information on the 
real incidence and prevalence of NZDs, corrected as far as possible for under-
reporting, and on the other components of the losses imposed on people and 
animals, that is, the total societal burden of these diseases. Quantifying the 
double whammy requires information gathering and analysis at three levels.
The fi rst is the burden of ill health in humans. This has two components: a 
monetary component made up of the costs to patients and health services, and 
a non-monetary component consisting of the value placed on human health, 
usually measured in terms of DALYs.  The DALY, like other measures of human 
health, was developed in order to provide a standard that can be universally 
applied across human populations and income groups. For human health, a 
non-monetary metric is considered ethically sound.  Global DALYs, adjusted 
for under-reporting, have been estimated for fi ve NZDs (cystic echinococcosis, 
alveolar echinococcosis, leishmaniasis, rabies, and trypanosomiasis); work on 
others is in progress.  The monetary component of the cost of human illness 
caused by NZDs is particularly high given the frequently lengthy process of 
getting health care (Chapter 6).
The second is analysing the other part of the double whammy in terms of the 
NZDs’ impact on animal populations, and the potential benefi t their control 
could bring to animal owners and livestock keepers. For some diseases, this is 
important, for others not. There are little data from the fi eld about the impact 
of NZDs on livestock in African, Asian and Latin American production systems, 
even for diseases such as brucellosis, cysticercosis and trypanosomiasis whose 
impact is signifi cant. For animals, there is no need to use a non-monetary 
metric like the DALY. Livestock have a commercial value, and techniques have 
even been developed for valuing wildlife and companion animals in monetary 
terms.  Livestock’s life expectancy is a function of their health, but ultimately of 
the husbandry system which determines the age at which they are marketed. 
Money enables different species to be compared; it would be inappropriate 
to attempt to compare goat DALYs with cattle DALYs and then weigh these 
against human DALYs. Well established methodologies for evaluating the impact 
on animal health already exist (see papers and methods set out in Rushton, 
2009), removing the requirement to develop novel approaches specifi cally 
for zoonotic diseases. Instead, the challenge is to use cost-effective ways of 
estimating the impact of disease by monitoring key indicators of fertility, asking 
livestock keepers about mortalities, fi nding out if draught animals are affected, 
interviewing butchers and livestock traders, and relating these to measured 
disease incidence or prevalence in the livestock populations.
Thirdly, there is a need to measure the impact of interventions on human 
and animal disease incidence and prevalence and to quantify their costs. 
Cost calculations need to be comprehensive and credible, including both the 
cost of the vaccine and its application, of the medicines or operation needed 
to treat a diseased person in hospital or at home and animals on a farm or in 
a nomadic herd. Only when these answers are known can the total burden of 
the double whammy be quantifi ed and the cost effectiveness of interventions be 
demonstrated.
Where the dual benefi ts 
of controlling NZDs are 
quantifi ed, the high cost-
effectiveness of intervening is 
very evident. When measured 
in US$ per DALY averted, 
the cost-effectiveness of NZD 
control is very attractive, often 
in the range of US$10–30.
Well established 
methodologies for evaluating 
livestock losses exist which 
can be combined with good 
information on DALYs. What 
we need more of is good fi eld 
data on impact on people and 
livestock.
At each stage of our work 
we also need to extract the 
data which show that these 
are diseases of poverty. For 
example, indicators of wealth 
for affected households and 
information on their access to 
health services are valuable 
for reinforcing the case for 
urgent intervention.
Alexandra Shaw 
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10 Analysing the burden of rabies
The health and economic burden of rabies is diffi cult to determine as the 
disease is thought to be vastly underreported for a number of reasons of which 
some also apply to many other infectious diseases.
 • The vast majority of deaths from rabies occur in resource poor  
  countries with inadequate infrastructure and health governance.
 • These countries most often also lack diagnostic capacity, leading  
  to a complete absence of laboratory based surveillance in
  humans and animals and signifi cant inaccuracies or   
  inconsistencies in disease estimation and reporting. 
 • Rabies is essentially a disease of dogs that have, in the developing  
  world (where these animals are mostly self-supporting), little  
  intrinsic value (compared to livestock, for instance).
 • Given the above in particular the lack of data on the extent to  
  which the animal population is affected, estimating total costs  
  associated with  the presence of the disease is diffi cult.
These observations are globally supported by analyses of rabies data reported. 
For example, country reports submitted to and presented at the international 
Southern and Eastern African Rabies Group (SEARG) meeting in 2008 revealed 
a staggering range of 0.019 to 150 when the ratio of human to animal rabies 
cases was calculated. It is estimated that  95% of human rabies deaths in Africa 
are not reported. Since human rabies cumulatively makes up more than 10% 
of the total (human and animal) rabies cases reported from Africa, the degree 
of underreporting of the disease in animals must be even worse, with probably 
less than 1% of cases being reported.  At the same time, the fi gures reported to 
different bodies, such as the OIE, WHO, SADC and SEARG, are essentially never 
in complete agreement. An example is from 2007, when one country reported 
87 animal rabies cases to OIE (World Animal Health Information Database – 
WAHID – reporting system), 302 to WHO (Rabnet reporting system) and 13 to 
SEARG
A benchmark study towards the quantifi cation of the burden of rabies in Africa 
and Asia has been published (Knobel et al., 2005). Using epidemiological and 
economic models and a series of probability steps, model outputs on mortality 
and morbidity were used to calculate a DALY score as well as the total societal 
cost due to rabies (estimated at US$ 583.5 million). Human mortality was 
estimated to be 55 000 deaths annually. Considering this model, the degree of 
underreporting is signifi cant indeed and superior to 90% in Africa and parts of 
Asia.
In recent months, a further community-based assessment of the global 
burden of rabies has been initiated. This effort is driven by an inclusive 
global community of rabies experts (Partners for Rabies Prevention) and 
the study will attempt several additions to the current model. First, to make 
the assessment truly global and also to evaluate the disease costs in those 
areas where human mortality is not necessarily high. Second, to add more 
epidemiological data generated in recent years and to add more information on 
the cost of vaccination programmes in the developing world. Whereas fi xed-
point vaccination campaigns were previously assumed across board, updates 
In contrast to the developed 
world, there is little 
indication of a realistic 
resolution over much of the 
rest of the world, certainly 
across Africa, given lack 
of resources, competing 
priorities, and the lack of a 
continent-wide movement or 
strategy.
Louis Nel
Worldwide, rabies is 
estimated to account for 1.7 
million DALYs.
Knobel et al., 2004
Rabies has the highest case 
fatality ratio of all infectious 
diseases. Much of the high 
DALY burden of rabies is a 
refl ection of the fact that up 
to half of victims are children 
with their premature deaths 
representing many life years 
lost.
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from regions where roaming vaccination is required will be considered. In 
this regard, at least three new programmes, globally driven by the WHO/Gates 
foundation and the respective governments of the Philippines, South Africa and 
the United Republic of Tanzania, have been launched during the past two years. 
New data from India, including epidemiological data and the recent signifi cant 
reduction of the production and use of nerve tissue vaccine PEP in South east 
Asia could also comprise important updates. 
A child’s view of rabies,  South Africa
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11 Investigating the burden of parasitic zoonotic diseases
Diseases resulting from zoonotic transmission of parasites are common. 
Humans become infected through food, water and close contact with animals. 
Most parasitic zoonoses are neglected diseases despite causing a considerable 
global burden of ill health in humans and having a substantial fi nancial 
burden on livestock industries. Because of under-reporting it is diffi cult to 
estimate what these burdens might be, so published studies tend either to be 
conservative or to cite a wide range. 
Global burdens of cystic and alveolar echinococcosis have been estimated; 
collectively, they result in at least 1.5 million DALYs and possibly considerably 
more (Budke et al., 2006; Craig et al., 2007; Torgerson et al., 2010). In 
addition, cystic echinococcosis results in losses of US$ 0.5–2 billion to the 
global livestock industry annually. An estimated 40% of the global burden of 
cystic echinococcosis and 90% of the burden of alveolar echinococcosis falls on 
a single country, China. Nine provinces of China alone estimate that 330 000 
cases of cystic echinococcosis occur annually as well as some 16 600 cases of 
alveolar echinococcosis. Ultrasound surveys in Tibetan areas of Sichuan and 
Quinghai indicate a prevalence exceeding 3.5% for both forms of the disease. 
In some Tibetan communities, echinococcosis is likely to be responsible 
for the largest burden of any infectious disease. In Tibet, it is estimated to 
account for an average of 0.81 DALY per person over their lifetime. Elsewhere, 
cystic echinococcosis has re-emerged in the Newly Independent States of the 
former Soviet Union and Eastern Europe, and is a major problem throughout 
the Middle East and parts of Latin America. The incidence of alveolar 
echinococcosis is increasing in Europe.
Cysticercosis caused by T. solium, also causes a major disease burden with 
perhaps up to one third of epilepsy cases in low- or middle-income pork-
consuming countries being associated with neurocysticercosis. China is 
also highly endemic for cysticercosis. The global burden is unknown but is 
thought to account for a substantial fraction (around 30%) of the burden of 
epilepsy in pork-consuming low-income countries, and this fi gure is confi rmed 
by a systematic review of studies on the frequency of neurocysticercosis 
(Ndimubanzi et al. 2010). The global burden of epilepsy is estimated at 7.8 
million DALYs, of which 6.5 million occur in sub-Saharan Africa, Latin America, 
South Asia and the Western Pacifi c (including China). 
Other parasitic zoonoses of importance include toxoplasmosis. Studies suggest 
that congenital toxoplasmosis, which involves mental retardation, epilepsy and 
blindness, results in approximately 2300 DALYs per year in the Netherlands 
alone, where it is the leading infectious foodborne disease, surpassing the 
burden of campylobacteriosis. If other syndromes are included, and with a high 
global prevalence, toxoplasmosis is likely to make a substantial contribution to 
the global disease burden.
Foodborne trematode infections (liver fl ukes and other infestations caused by 
species of Fasciola, Clonorchis and Opisthorchis) are common in some societies 
and may result in more than 10 000 deaths annually. For fascioliasis, livestock 
losses alone are estimated to account for some US$ 3 billion. 
Although the global burden for 
most parasitic zoonoses is not 
yet known, it is clear is that, 
collectively, parasitic zoonoses 
probably have a similar human 
disease burden to any one of 
the big three human infectious 
diseases: malaria, tuberculosis 
or HIV. In addition many also 
have a substantial animal 
health and economic burden.
Paul Torgerson 
and Philip Craig
Globally, the burden of the 
two forms of echinococcosis 
is at least 1.5 million DALYs 
annually, and may be 
substantially higher. 
Some 75 000 or 5% of the 
1.5 million DALYs ascribed 
to sleeping sickness (human 
African trypanosomiasis) 
are thought to be due to the 
zoonotic form
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The burden of schistosomiasis is likely to be revised substantially upwards 
when the new disability weights developed by WHO are applied. The zoonotic 
form of schistosomiasis, Schistosoma japonicum, accounts for a signifi cant 
proportion of that burden.
Other major contributors to the burden of parasitic zoonoses are Leishmania 
spp. and Trypanosoma spp. Furthermore, accurate diagnosis or detection of 
parasitic or microbial zoonoses in humans and animal hosts is critical to assess 
their burden, especially for active mass screening or epidemiological surveys, 
but may not always be straightforward. 
Mass screening by ultrasound for abdominal echinococcosis in Tibetan communities of north-west 
Sichuan, China 
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12 Reviewing the burdens of brucellosis, bovine TB and other bacterial diseases
Bacterial zoonoses such as brucellosis, bovine tuberculosis and anthrax have 
been successfully controlled or eliminated by effective and well managed 
vaccination and/or test-slaughter strategies in many industrialized countries. 
The cost of control was essentially borne by national governments, including 
the cost of acceptable compensation for culled animals. These zoonoses, 
however, remain endemic in humans and in livestock in the Mediterranean, 
Africa, the near East and Central America, and are re-emerging in the newly 
independent states of the former Soviet Union and Mongolia.
Under the auspices of WHO’s Foodborne Disease Burden Epidemiology 
Reference Group (FERG), the burden of some of these diseases is being 
estimated or re-assessed. This work should provide estimates for DALYs and 
global disease patterns. Many countries, however, lack the diagnostic capacity 
to make a comprehensive estimate of the burden of disease. Individual 
zoonoses are not categorized in human reporting systems and hence are 
often not reported as causes in death certifi cations. Initial work has begun 
to systematically review the burden of brucellosis by screening some 10 000 
articles (after elimination of duplicates) and by selecting some 150 articles for 
further analysis, of which nearly half relate to Europe. The lack of information 
on the disease’s frequency, especially in Africa, brings it closer to a gap analysis 
than a full burden of disease study. 
Furthermore, along with the other NZDs, bacterial zoonoses have important 
non-health outcomes in terms of public and private health cost, and costs to 
agriculture and other sectors of the economy. They also affect foreign trade. 
Work on the cost of bacterial zoonoses shows different patterns from Central 
Asia and Africa. The fi nancial costs of brucellosis to society are substantial for 
countries such as Kyrgyzstan and Mongolia, and are likely to be higher than 
the cost of effective mass vaccination; Livestock immunization can therefore 
be justifi ed in fi nancial terms as well as via the impact on human health as 
measured in DALYs (see Roth et al., 2003). Herd models such as the FAO 
Livestock Development Planning System can be used to simulate the impact of 
disease (see http://www.fao.org/agriculture/lead/tools/livestock0/en/).  
However, the costs of bovine tuberculosis to livestock keepers seem to be rather 
moderate and may not justify interventions purely from a fi nancial perspective. 
On the other hand, private contributions to disease control activities seem 
possible: Chadian farmers are willing to pay for anthrax vaccine provided 
its quality is satisfactory. The costs of foodborne bacterial zoonoses such as 
Campylobacter and Salmonella are barely assessed economically. A ‘One 
Health’ approach, which considers the health of humans and animals as part 
of a socio-ecological system, supplies the tools for assessing the burden of 
bacterial zoonoses to human and animal health, including non-health outcomes 
and the fi nancial cost of disease to society. Such assessments may provide the 
necessary arguments for decision-makers in low- and high-income countries 
to adjust interventions not only for clinical management but also to target the 
root causes of disease, which are mostly outside the human health systems.  
For example, mass vaccination of livestock, environmental sanitation, abattoir 
hygiene and food safety are needed to deal effectively with these causes.
For brucellosis and bovine 
TB, advocacy for the control 
requires better understanding 
of their health and economic 
burden. Such information is 
important for the assessment 
of the profi tability and cost-
effectiveness of potential 
future interventions as most 
endemic countries have limited 
public funds.
However, in most countries 
their importance in terms of 
burden of disease and societal 
cost is neither precisely – nor 
even approximately – known.
Jakob Zinsstag
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13 Understanding the burden of Rift Valley fever: lessons from the Horn of Africa
Rift Valley fever is a mosquito-borne viral zoonotic disease that affects domestic 
ungulates (sheep, goats, cattle, camels, domestic buffalo) and humans. Large 
epizootics associated with outbreaks in humans occur during periods of heavy 
and prolonged rainfall, every 8–10 years historically. Until 1977, the disease 
was reported only from the east (Horn of Africa) and southern mainland of sub-
Saharan Africa. Since then, it has extended its range in three directions: north 
to Egypt, where an outbreak in 1977 caused an estimated 200 000 human 
cases, of which 18 000 were reported, including 598 deaths; west to Mauritania 
and Senegal, where a large epidemic in 1987 caused more than 200 human 
deaths; east to Madagascar where the disease was fi rst reported in 1979 and 
where several outbreaks occurred in 1990–1991.
In 1997–1998, a large outbreak occurred in humans in the Horn of Africa, 
with an estimated 90 000 human cases, including 478 deaths. The associated 
epizootic resulted in signifi cant losses in livestock, particularly of sheep and 
goats: approximately 70% died in the affected areas. This outbreak led to 
the fi rst ban on exports of livestock from the Horn of Africa imposed by the 
Gulf countries. Given that livestock production and trade are vital to the 
livelihoods of the region’s pastoralists (who constitute a large segment of the 
area’s communities) and are an important source of public revenue, one can 
understand why the estimated losses caused by that ban amounted to around 
US$ 350 million. A second ban on live animal exportation was imposed by 
the Gulf countries after the 2000 outbreak in Saudi Arabia and Yemen which 
resulted in more than 3500 human cases, including 208 deaths. This second 
ban led to even larger losses than the fi rst.
Rift Valley fever struck again in the Horn of Africa on a large scale in 2006–
2007, causing 350 confi rmed human deaths. In 2007–2008, an outbreak 
in Sudan resulted in a further 230 human deaths. Economic losses in the 
associated epizootics were great but have yet to be quantifi ed.
Rift Valley fever thus constitutes an important public health problem as well as 
a serious socioeconomic burden on an area already vulnerable to many natural 
and human-made disasters. 
The economic losses due to 
the 1997/98 Rift Valley fever 
outbreak in the Horn of Africa, 
where economies are heavily 
dependent on livestock kept by 
pastoralists, were estimated 
at US$ 350 million. In 2002, 
losses in Somalia alone were 
estimated at  US$ 326 million.
The 2006/7 outbreak 
underlined how severe the 
disease in humans can be. The 
mild fever form of the disease 
probably goes unreported. But 
among reported human cases 
the case fatality rate was up 
to 45%.  
Zuhair Hallaj
Country Reporting  Reported Reported Reported case
 period cases deaths fatality rate (%)
Kenya 2006–2007 684 155 23
Somalia 2006–2007 114 51 45
United Republic 2007 264 109 4
of Tanzania
Sudan 2007–2008 723 230 32
The Control of Neglected Zoonotic Diseases
24
14 Leptospirosis: overlooked worldwide
Linked with the presence of rodents and poorly controlled water sourses, 
leptospirosis is a problem worldwide but remains predominantly a disease 
of poverty. Inadequate fl oodwater drainage, poor hygiene and sanitation, 
over-crowded housing – the characteristics of rural or peri-urban slums – all 
favour its transmission. Males in their mid 30s are the group at highest risk.  
During the past fi ve years, signifi cant outbreaks have been recorded across the 
world ranging from the Americas (eight countries) to Europe and the eastern 
Mediterranean (nine countries); Africa (one country) and South-East Asia and 
the Western Pacifi c (nine countries). 
The Leptospirosis Burden Epidemiology Reference Group (LERG) is 
investigating the burden of the disease. From a review of incidence studies, 
it is clear that the disease is ubiquitous; particularly high incidence rates are 
recorded in Africa, parts of the Americas and the Western Pacifi c (median 
incidences from published studies of 95.5, 12.5 and 66.4 per 100 000 people). 
The effect of the disease on patients reveals a substantial proportion suffering 
acute febrile illness, which may lead to acute renal and/or lung injury. Of the 
estimated 17% of hospitalized patients who suffer acute lung injury, 25% die as 
a result. The overall human case fatality rate is estimated at 7%.
Key gaps identifi ed by the Group are:
 • point-of-care diagnostics for acute leptospirosis 
 • insuffi cient incidence and long-term studies for directly assessing  
  the burden of disease;
 • insuffi cient understanding of environmental and climatic drivers;
 • guidance for outbreak response and clinical management; 
 • protocols for surveillance of disease and infection sources. 
 • Lastly, vulnerable groups at risk need to be identifi ed and targeted.
Moving from a global to a country and then to a community perspective will be 
vital to contextualize the knowledge gathered in order to increase awareness at the 
national and community levels among health-care providers and the public, and to 
guide policy towards improved integrated prevention, control and response.
Studies investigating 
leptospirosis  have shown an 
incidence as high as 975 per 
100 000 people in some high 
risk areas.
Effective control requires much 
greater awareness and the 
targeting of vulnerable groups 
at risk
Bernadette Abela-Ridder
Peri-urban living conditions where leptospirosis studies have shown a high incidence, Salvador, 
Bahia, Brazil 
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Useful websites to visit are:
http://www.who.int/zoonoses/
diseases/lerg/en/index.html
http://www.who.int/rpc/
evipnet/en/ 
Leptospirosis predominantly 
affects marginalised low-
income populations.
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15 Neglected zoonotic diseases and reassessing the Global Burden of Disease 
The re-assessment of the Global Burden of Disease (GBD) is a major 
undertaking funded by a US$11 million grant from the Bill & Melinda Gates 
Foundation, led by the Institute for Health Metrics and Evaluation (USA), WHO, 
Harvard University (USA), the University of Queensland (Australia), Johns 
Hopkins University (USA) and the WHO’s Health Statistics and Informatics 
Department. The task involves a complete revision of the Global Burden of 
Disease, examining all causes, risk factors and disability weights. The work 
began in 2007 and hopes to be complete within 5 years. The objective is to 
provide new estimates of disease, injury and risk factors for 1990, 2005 and 
2010 for all WHO regions, thus spanning the global population.  There are 
approximately 40 expert groups involving some 350-600 experts.
The DALY will continue to be used as a basic metric, with its two classic 
components: years of life lost due to premature mortality (YLL) and equivalent 
years of healthy life lost due to disability (YLD).  The YLDs are measured in 
terms of the duration of disability and the weight of disability. The reassessment 
will pay particular attention to disability weights. It will derive weights for 
all unique sequelae in the study (around 230), which capture the major 
health consequences of all of the causes in the study. The new approach 
aims to address criticisms of previous approaches by focusing on valuations 
from community respondents in a diverse range of settings and by using 
techniques for eliciting responses that are well-matched to the intended 
measurement construct (loss of health). Thus it hopes to develop a transparent, 
standardized and replicable approach that will easily accommodate additions or 
amendments.
This will be particularly important for the NZDs, some of which can involve 
long term disfi gurement (leishmaniasis), others chronic pain or fatigue/
depression (brucellosis). In this context, dog bites from rabies will now be 
included among injuries, although it is not practical to factor in consequences 
such as mental anguish while patients wait for the outcome of diagnostic tests 
to fi nd out if they have or have not contracted rabies. New risk factors, such as 
genetic predisposition, will be included.  Although poverty will not be taken into 
account explicitly, the regional divisions will provide some basic indication.
To date, the results from the consultation have been encouraging. Large 
amounts of measurement error in individual responses do not preclude 
successful estimation of population values. There has been a very high level 
of consistency in responses across sites. Preliminary analysis of partial results 
from a telephone survey carried out in the United States indicates further 
consistency across cultures. Most results yield plausible orderings, while a 
few implausible results point to important considerations for clarity in the 
descriptions formulated for the understanding of  non-medical people. 
Several individual NZDs are 
now the subject of expert 
groups:
 • African trypanosomiasis
 • rabies
 • leishmaniasis.
Many of the NZDs are focal 
diseases and for these it is 
particularly important to 
be careful when estimating 
the population at risk so 
that study populations are 
appropriately matched to at 
risk populations in order to 
avoid study population bias. 
This is a particular challenge 
for researchers.  
Colin Mathers 
More information can be found 
at: www.globalburden.org
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16 Rabies: a re-emerging disease in China
Following successful control during the early 1990s, the number of cases of 
rabies in China was reduced to fewer than 200 cases annually by the mid-
1990s. Since 2000 however the incidence in humans has risen to a peak of 
3300 cases in 2007. Rabies in China is predominantly a rural problem, where 
the number of dogs per person (1 per 5 people) is four times higher than in 
urban areas.  Only 10% of dogs are registered, predominantly those kept in 
urban areas.  Around 5% of people are thought to be bitten by dogs annually, or 
some 68 million potential rabies exposures; surveys indicate that fewer than 5% 
of the dogs implicated were vaccinated.
Lack of knowledge of the disease is a major factor contributing to its re-
emergence; people are not always aware that rabies is a fatal disease or of the 
availability and need for post-exposure prophylaxis (PEP). Furthermore, for 
people living in rural areas, a full post-exposure prophylaxis regimen  (vaccine 
and immunoglobulin) is often unaffordable costing around1500 Yuan  (US$235) 
for an average per capita annual income around 3000 yuan.
The capacity of offi cial veterinary services to vaccinate large numbers of dogs 
is limited. National laws and regulations for humane dog management are 
lacking, as is integrated laboratory-based rabies surveillance. 
Responding to this situation, the public health services have mobilized 
considerable resources. In 2004, a mandatory national internet-based 
notifi able disease reporting system was introduced. This is reinforced by 
sentinel surveillance. In 2006, social mobilization, health education and health 
promotion activities included a large-scale health education plan. The Ministry 
of Health also produced national guidelines for PEP in 2006, which were 
revised in 2009. This work has been accompanied by a national programme 
of teaching and training on PEP for doctors. The availability of PEP has been 
greatly increased, especially in the countryside. The public security department 
is responsible for urban dog populations and the veterinary department for  
the management, immunization and surveillance of the rural dog populations.  
NGOs and the public media have also been mobilized.
In 2009, the number of human rabies cases had already fallen by more than 
one third. The Ministry of Health is actively promoting rabies elimination by 
2020 as a national goal. 
90% of human rabies cases 
occur in remote rural parts of 
southern China affecting poor 
farmers and their children.
Yin Wenwu
The goal: rabies elimination by 
2020!
The key to success is 
the involvement  of all 
organisations in veterinary 
and human health fi elds, as 
well as non-governmental 
organizations (NGOs) and the 
media.
Rural areas have high dog populations and people are often too poor to pay for post exposure 
prophylaxis if they are bitten.
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17 Going for elimination: dealing with rabies in the Philippines 
Rabies remains an important public-health problem in the Philippines. It is 
the most acutely fatal infectious disease, responsible for the deaths of 200–300 
persons annually, almost half of whom are children aged under 15 years. 
Some 200 000 dog bites are reported annually. PEP for victims of animal bites 
entails considerable expense, estimated at more than US$ 1.5 million per year 
by the Department of Health. Despite the limited resources for rabies control, 
signifi cant gains have been achieved in controlling rabies during the past 15 
years. Although cases of human rabies have declined by 60% since 1995, 
victims of animal bites or rabies exposure presenting at treatment centres 
have steadily increased. The setting up of these treatment centres, which now 
number 311, has signifi cantly increased access to PEP; most rabies exposures 
receive at least four doses of vaccine injected intradermally free of charge. 
Canine rabies has also been declining, with the number of reported cases of 
animal rabies down to 40% of their level a decade ago. The Department of 
Health’s rabies budget has quadrupled since 2008, with the passage of the Anti-
Rabies Act of 2007.
The National Rabies Prevention and Control Programme is implemented 
by a multi-agency, multi-sectoral committee chaired by the Bureau of 
Animal Industry of the Department of Agriculture; a representative from the 
Department of Health is designated as its Vice-chairperson. Other members 
include the Department of Interior and Local Government, the Department 
of Education, the Department of Environment and Natural Resources, local 
government units, NGOs and people’s organizations. Activities are based 
on vaccinating dogs, providing PEP to victims of dog bites, vaccinating 
preventively high-risk groups, including school-children, in endemic areas, 
providing education and information on rabies, and promoting responsible pet-
ownership. 
The creation of rabies-free zones is an important step in the process. The island 
province of Siquijor was declared as the fi rst such zone in the country in 2008; 
Batanes and the Apo Island of Negros Oriental were declared rabies-free in 
2010. A further initiative, “Bantay Rabis Sa Barangay”, makes  a person in the 
barangay (the smallest political unit of a city or municipality) responsible for 
ensuring that all dogs are vaccinated. 
Our goal: to eliminate human 
rabies in the Philippines 
and declare a rabies-free 
Philippines by year 2020.  
Raffy Deray
In the Philippines, the passing 
of a rabies control act and 
commitment at national 
level with a multi-sectoral 
National Rabies Committee, 
with specifi c rabies elimination 
initiatives undertaken by 
national, provincial and city/
municipal governments, 
combined with community 
involvement at the “barangay” 
level is proving an effective 
recipe for success. 
Pupils unravelling the fatal disease – Rabies. Philippines, 2009
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18 Sierra Leone’s animal health clubs: a new way to engage communities 
In Sierra Leone, the civil war (1991–2002) and the resulting breakdown of all 
public services have contributed to rabies endemicity in the entire country. 
Human rabies is not a notifi able disease, so it remains invisible to the public 
health system and  no resources are allocated to its prevention and control. 
There is no reporting mechanism for dog bites and no standard protocols 
for dealing with suspected rabid dog bites – neither capture and observation 
of dogs, nor treatment of human bite wounds and PEP. The problem is 
compounded by lack of readily available vaccines for either humans or animals. 
Even when these vaccines are available, most families cannot afford the cost of 
vaccinating dogs, let alone of human PEP. In 2008, it was clear that rabies was 
a signifi cant threat to animal and public health.
With the end of the war in 2002, rabies control activities were rekindled in 
Freetown through the efforts of the Sierra Leone Animal Welfare Society, 
which launched its Humane Dog Population Management programme in 2005. 
However it is clear that much more needs to be done. In response to this, a 
group of lecturers at Njala University, conceived the idea of Animal Health 
Clubs (AHCs), as an innovative approach to rabies control that engaged and 
empowered communities to prevent animal and human diseases, focusing on 
education and raising awareness to prevent dog bites and canine rabies.
The process of establishing AHCs begins with a pilot project, done with the 
support of the Paramount Chief and his chiefs in the project locations. Head 
teachers and principals are informed and teachers are assigned to form clubs 
in their schools. Then, university lecturers train the teachers, students and 
farmers in animal welfare issues, management, disease prevention and control, 
environmental management, wildlife issues, animal and human nutrition and 
appropriate technology. The teachers, in turn, train club members. Large towns 
are divided into zones - each with an AHC chairperson. On weekends, the 
teachers, pupils, students and lecturers are divided into teams and sent to work 
in communities with their zonal chairpersons.
The initial success of pilot projects close to Njala University encouraged the 
replication of the project in the large towns of Bo, Kenema and Makeni in 
conjunction with World Rabies Day 2010. The celebration was the fi rst of its 
kind in the history of Sierra Leone. It attracted people from all walks of life 
including traditional chiefs and rulers. There was support and participation by 
representatives of the Ministries of Agriculture and Health, the United States 
Centers for Disease Control and Prevention (CDC), and FAO.
The fi rst AHCs were formed in 
2008 to commemorate World 
Rabies Day. They included fi ve 
schools and seven villages 
near Njala University. Today, 
membership comprises 
primary school pupils aged 
as young as seven years to 
university students, along 
with teachers, lecturers, and 
farmers in rural communities. 
There are currently about 
100 schools in the Northern, 
Southern and Eastern 
Provinces with the AHCs. Njala 
University is the technical 
leader and has enlisted the 
support of nearly 2,000 
farmers in AHCs.
Roland Suluku
Advertising a new idea
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19 Tackling two neglected zoonotic diseases in Peru: rabies and fascioliasis
Rabies
An average of 27 cases of human rabies transmitted by dogs were recorded 
annually during the period 1990–1994. Since the launch in 1993 of the Urban 
Rabies Elimination Plan by the Ministry of Health, supported by WHO / PAHO 
(Pan-American Health Organization), there has been a marked decrease. The 
last recorded clinical case of human rabies was in 2006, in the Department of 
Puno, located on the southern border with the Plurinational State of Bolivia. 
During the same period, an average of 575 canine rabies cases were reported 
annually. With the launching of the National Elimination Plan, a progressive 
decrease has been noted and nowadays the canine rabies incidence has been 
reduced by more than 90%.
Persons bitten by domestic animals, principally dogs, receive appropriate care 
in all health institutions. During the period 2005–2009 on a yearly average 65 
000 people bitten by suspect animals received post-exposure prophylaxis at an 
estimated cost of US$ 900 000. The observation of biting animals complements 
the prescription of human post-exposure prophylaxis and is mostly carried out 
at household level. Dedicated “anti-rabies centres” where dogs and cats are 
observed are only present in some cities. During 2004–2008 approximately 
80% of the biting dogs underwent observation in the departments with high 
numbers of canine rabies cases.
The success of the plan is based on executing three strategic components:
 • paying attention to persons potentially exposed to the rabies virus,
  prioritizing the clinical observation of biting animals as a   
  complement to post-exposure prophylaxis;
 • undertaking free of charge mass dog vaccination campaigns,  
  implemented over short periods of time, using locally produced  
  vaccines and involving the whole health-care system by integrating  
  the efforts and resources of local bodies such as municipalities,  
  universities, armed forces and others;
 • strengthening health education for a timely notifi cation of any  
  animal bite and promotion of dog ownership, emphasizing the  
  “triad for the prevention of rabies” (see poster below) with active  
  participation of local governments.
The last recorded human 
rabies clinical case occurred 
during the fi rst semester of 
2006 and only 13 cases of 
canine rabies were reported 
during the fi rst 10 months of 
2010. 
Since 2005 an area comprising 
22 departments, accounting 
for 88% of Peru’s land area, 
95% of the human population 
and 95% of the dog population 
has been free of canine rabies  
Ana María Navarro Vela
Publicity is a vital 
ingredient for success. 
A Peruvian stamp with the 
logo of “World Rabies Day” 
(WRD) – the release of this 
stamp was named “the 
best WRD international 
event for the year 09” by 
the Alliance for Rabies 
Control. 
A poster warning about rabies and 
explaining what to do if you are bitten by 
a dog
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Human fascioliasis
Fascioliasis in Peru is caused by Fasciola hepatica, a parasite that commonly 
affects cattle and sheep and occasionally humans. This disease contributes 
to aggravating poverty in affected communities. In Peru, high rates of human 
and animal fascioliasis are recorded, mostly in the departments of Cajamarca 
and Puno and Valle del Mantaro in Junin department. Prevention and control 
programmes have mainly aimed at controlling the disease in livestock to reduce 
its economic impact. 
In the recent past control in the human population was diffi cult as the clinical 
picture is often not characteristic, existing diagnostic tests have low sensitivity 
and specifi city and because of the absence of a specifi c treatment.
In 2007, a meeting on the prevention and control of fascioliasis in Peru, with 
participation of the national and Cajamarca Ministries of Health, Agriculture 
and Services of Animal Health, the Universidad Peruana Cayetano Heredia 
and Universidad Nacional Mayor de San Marcos was organized with WHO / 
PAHO assistance to strengthen inter-institutional technical cooperation. The 
meeting identifi ed endemic communities in the departments of Cajamarca, 
Junin and Puno, developed intersectoral prevention and control programmes 
and proposed for the fi rst time a strategy for the mass treatment of fascioliasis 
in affected human populations. A triclabendazole donation for the treatment 
of 600 children of school age was obtained with WHO/PAHO support and used 
successfully in a pilot project in the endemic areas of Cajamarca between 
November and December 2007.
Based on this fi rst experience, a methodology for intervention has been 
established in high risk districts through sampling and testing a sample of the 
school children aged 6–15 years. When fi nding a positive case for Fasciola, 
all the children in the same classroom, all family members and all community 
members of the positive case were treated. The same methodology was used 
in a mass treatment campaign thanks to a donation of 200 000 tablets of 
triclabendazole from Norvatis through WHO.
In 2008 and 2009, through the application of this methodology, 34 792 
schoolchildren and adults in two provinces of the department of Cajamarca 
and 617 people in a province of Junin department were treated against 
Fasciola using about 123 000 triclabendazole tablets distributed to. During 
the pilot programme and the following mass treatment campaign no adverse 
effects requiring therapeutic support were reported. In parallel with this the 
Cajamarca regional government and the national animal health service have 
been implementing a project to control hepatic distomatosis in livestock.
In endemic areas of Peru the 
prevalence of fascioliasis 
infestation can be as high as 
50% in schoolchildren and 
over 90% in livestock. 
For the fi rst time, infected 
children, their classmates  
their family and community 
members were treated  against 
fascioliasis. 
In the study population, before 
treatment 17% of children and 
9% of adults were infected.
The success of the programme 
depended on intersectoral 
cooperation, including 
simultaneously treating 
animals..
Ana María Navarro Vela
Schoolchildren are a high-risk group in these remote mountain communities
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20 Finding an “emerging” problem: fascioliasis in Viet Nam 
Since 2004, work to increase awareness of fascioliasis in communities and to 
improve the capacity to diagnose it has been undertaken in Viet Nam. From 
2004 to 2006, human fascioliasis cases were found in 132 out of a total of 681 
districts with more than 80% of these cases found in the centre of the country. 
Over 90% of the patients were over 15 years of age and about 62% of reported 
cases were female. 
Two different types of freshwater snails were found to act as intermediate hosts, 
one found in rice fi elds in both highland and plain locations, the other in small 
channels. Very high infection rates were found in livestock hosts: up to 98% in 
buffalo, 71% in goats and 31% in cattle, depending on the location.
The programme involved training health staff in fascioliasis diagnosis 
and treatment at district and provincial levels in 41 provinces. Most of 
the hospitals at province and district level have ultrasound and many can 
diagnose fascioliasis. Since 2004, 52 300 tablets of triclabendazole (for 25 
000 treatments) were donated by Novartis through WHO to hospitals in Viet 
Nam. Information, education and communication (IEC) activities to prevent 
fascioliasis were carried out at all levels – posters were produced and 
loudspeakers used to broadcast to villagers.
As result of this enhanced awareness at the community level, better training of 
clinicians and better diagnostics, the reported cases of fascioliasis in Viet Nam 
have been increasing year by year: 2007: 1600; 2008: 2250; 2009: 4300.
Now that more and more fascioliasis patients are receiving appropriate 
treatment, the challenge will be to work on transmission control. First, in 
collaboration with the veterinary sector, livestock deworming needs to be 
promoted, although it likely to be diffi cult to persuade farmers to comply with 
this. A second option is treating water used in agriculture so as to kill Fasciola 
metacercaria, although there are no good models for achieving this. Lastly, 
an  option would be to convince people to stop eating raw or undercooked 
vegetables.  As people tend to be reluctant to change long-standing eating 
practices, dedicated health education programmes will be needed
Three reasons why fascioliasis 
has been apparently 
‘emerging’ in Viet Nam:
 • awareness of fascioliasis  
  has increased: since 2006,  
  information on fascioliasis  
  was distributed through  
  media to the citizens;
 • more local health workers  
  are able to diagnose   
  it: training of local health  
  staff has been carried
  out at provincial and   
  district levels; 
 • improved diagnostic   
  methods: diagnostic tests 
  are available at provincial  
  level and ultrasound is  
  available at the district  
  level.  
Do Trung Dung
Educating and involving communities: using a loudspeaker to broadcast information about 
fascioliasis prevention and control to communities. 
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21 Dealing with a large-scale problem: echinococcosis in Xinjiang, China 
Human echinococcosis, both cystic and alveolar, is a signifi cant public health 
and economic problem in the endemic regions of China (Xinjiang, Gansu, 
Tibet, Inner Mongolia, Qinghai, Ningxia and Sichuan). Nearly 11 000 cases of 
echinococcosis were found during the initial national survey in 2004–2008.
 In the early 1980s, the People’s Government of the Xinjiang Uygur Autonomous 
Region began to better understand the severity of the problem posed by 
echinococcosis, and to pay greater attention to its prevalence and distribution. 
An initial control programme took place from 1986–1995, which included 
deworming dogs. The government also spent signifi cant human, material and 
fi nancial resources to control and prevent the disease. Medical and disease 
prevention specialists worked together and multistage prevention and control 
measures were established and various treatment methods evaluated.
 
Transfer payments from China Central Government for surgical treatment 
of human echinococcosis were initiated in 2006. The Health Department of 
Xinjiang Autonomous Region despatched a group of experts to make an on-
the-spot investigation in 40 medical institutions in 29 prefectures. The Xinjiang 
medical university hospital and Shihezi university medical school hospital were 
designated “surgical technical guidance hospitals” and 16 other hospitals were 
also designated for surgical treatment. A computer -based network was used 
to carry out telepathology (remote) consultations for more than 800 patients. 
Approximately 500 patients were provided free surgical interventions.
 
Training programmes, books and audiovisual materials were developed and 
completed. Relevant training courses were repeated on 12 occasions for the 
designated medical institution in Xinjiang, Gansu, Tibet, Inner Mongolia, 
Qinghai, Ningxia and Sichuan provinces. Two technical guidance hospitals also 
sent experts to provide technical guidance for on-the-spot surgical, imaging, 
anaesthesia and nursing to designated medical institutions in 7 provinces.
The key to success was providing a model for human health interventions that 
combined questionnaires, health education, abdominal ultrasound screening and 
blood tests followed by treatment using percutaneous drainage of echinococcal 
cysts and surgical intervention, all carried out by a dedicated fi eld team.
A concerted campaign has led 
to a considerable improvement 
of the human echinococcosis 
situation, with human 
mortality and morbidity 
gradually decreasing as well 
as the proportion of infected 
animals. Echinococcosis is 
now considered a sporadic 
disease or a disease  of low 
endemicity.
Hao Wen
Analysing hospital data from 
over 2000 cases, the average 
direct economic burden was 
about 12,000 Yuan (US $ 1880) 
per person, and the indirect 
economic loss was 11,000 
Yuan per person(US $ 1730), 
equivalent to a total of 2 years 
average per capita urban  
income (per capita GNP).
Animal health  interventions 
such as dog faeces sampling, 
testing and dog deworming 
have also been carried out on 
a large scale.
Free albendazole tablets were given to cystic echinococcosis patients who were found in the 
Dangxiong survey in Tibet
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22 Community-led total sanitation (CLTS): empowering communities
Lack of sanitation is a huge problem that is seldom talked about. Some 2.6 
billion people defecate in the open every day, leaving behind hundreds of 
millions of kilogrammes of faeces.  Lack of effective latrines is linked to a host of 
diseases – whether via water contamination, direct contact or indirectly, as with 
a zoonotic disease like T.Solium teaniosis/ cysticercosis, whose transmission 
depends on roaming pigs grazing on human faeces and environmental including 
water contamination by human faeces.. Many well-intentioned and well-funded 
projects have, over decades, spent time and money in the world’s poorest 
communities building latrines, providing educational materials, generously 
subsidizing this work. However, the overwhelming evidence is that these 
approaches produce neither lasting solutions nor lasting behavioural changes. 
The problem lies in “outsiders” expecting to change the behaviour of “insiders”. 
Community-led total sanitation (CLTS) was developed out of the belief, and then 
the experience, that change can only come from within.  The CLTS approach 
involves a number of simple, but vital steps. Members of the community are 
brought together and a number of joint activities undertaken, using standard 
participatory methods.  
The methodology involves the community drawing a large map of their village 
or neighbourhood on the ground showing main landmarks such as a school, 
mosque/church/temple, roads, paths and water sources.  Places of open 
defecation (OD) are marked and traced to people’s homes. Next, the amount of 
human faecal matter produced per day, month and year by men, women and 
children is calculated. Families then calculate how much money they spend 
per month, then per year on treatment of diarrhoea, dysentery and other 
enteric diseases caused by OD. The main areas of OD are visited and then the 
possible faecal-oral contamination routes are discussed by adults and children 
separately, and illustrated or written down. Finally, a meeting takes place where 
faeces collected during the OD area walk are placed on a plate near fresh food. 
At this point the cumulative disgust at OD and its implications usually peaks 
– and the ‘triggering moment’ is reached, where the community unanimously 
decides to deal with the problem and to become OD free. 
CLTS has now been successfully introduced in 25 countries. 
In today’s world more people 
have access to mobile phones 
than to sanitation.  
Kamal Kar
Once a community has been 
‘triggered’, action happens 
FAST – people don’t say – ‘oh 
we’ll do this in 6 months’. 
Latrines are built by the 
community; the practice of 
open defecation is stopped by 
collective community decision 
and social solidarity. A number 
of other hygienic practices – 
such as handwashing – are 
also introduced. CLTS can act 
as an entry point for other 
changes.  
Kamal Kar
The CLTS website www.
communityledtotalsanitation.
org has much information 
about CLTS in different 
countries, useful links as well 
as publications and reports, 
including Kar (2010).
The fi rst ever CLTS  ‘triggering’ event  in the Democratic Republic of the Congo took place in 
December 2010. It was organized by Tearfund and conducted by the CLTS team from Plan Kenya 
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23 Using a novel form of cysticercosis control in Zambia and measuring its impact 
In Zambia, pig-keeping has increased rapidly in recent years. Both exotic pigs 
and the local Nsenga breed are raised. Most pigs are free-ranging and many 
villages lack proper sanitation. Cysticercosis is endemic in pig-rearing areas of 
the country. Pork is often consumed un-inspected – hence with cysts.. As yet 
no evidence is available that human neurocysticercosis, an important cause 
of epilepsy in the region, is present, but it is likely  to  be widespread in these 
endemic areas.
There are no existing community-based prevention and control programmes 
aimed at controlling NZDs in Zambia. Community-led programmes are a 
practical and successful way of promoting control strategies in a targeted and 
sustainable way in both rural and peri-urban areas. It is quite clear that in 
Zambia, cysticercosis is perpetuated by open defecation (OD). However, plans 
are underway to introduce a community -led total sanitation (CLTS) approach 
in two pig-keeping districts (Monze and Gwembe) with support from UNICEF, 
and, most importantly, to monitor its impact under an EU-funded research 
project (Integrated control of neglected zoonoses – ICONZ). The aim is to use the 
principles of CLTS to change people’s attitudes and behaviours regarding OD, 
with the goal of blocking cysticercosis transmission. It is also expected that this 
will have an important impact in reducing other faecally transmitted parasitic 
as well as diarrhoeal diseases. Control of cysticercosis could be integrated 
with that of trachoma since its control is based on improving environmental 
sanitation and provision of clean water. Improved sanitation also has various 
indirect impacts such as an improved environment free from odour, faeces and 
with increased privacy.
CLTS can yield successful results in Zambian communities: A CLTS pilot study 
reported an increase in the local population using a latrine from 23% to 88% 
within 2 months. However, the impact of CLTS on disease occurrence has not 
yet been measured, hence the need to evaluate it. Our research project aims 
to try and assess the impact of CLTS on T.Solium teaniosis/ cysticercosis  and 
on other diseases. It will also record the costs of introducing CLTS to the 
communities with a view to estimating its cost-effectiveness. 
Overwhelming evidence exists 
showing cysticercosis is 
endemic in Zambia. The severe 
health risks associated with 
this disease dictate the need 
to pilot a control programme 
that allows community 
participation to ensure 
capacity building, acceptance 
and sustainability.
Chummy Sikasunge 
Chibolya livestock market in Lusaka ~ livestock come from all over the country, but many are not 
inspected before slaughter.
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24 The challenge of containing zoonotic trypanosomiasis in Uganda
Uganda is the only country in Africa where both the acute zoonotic form of 
trypanosomiasis (caused by Trypanosoma brucei rhodesiense) and the chronic 
form (caused by T. b. gambiense) are found.  As the map below shows, the 
gambiense form of the disease occurs in the northwest of the country, where 
some 2 million people are at risk, while the zoonotic, rhodesiense form is found 
in the southeast, where some 8–9 million people are at risk. The two forms of 
sleeping sickness have always been distinct and separate. However, since 1998 
there has been a gradual expansion north-westwards of the rhodesiense form of 
the disease, with districts north of Lake Kyoga (in the centre of the country) being 
affected for the fi rst time. Cattle are the main reservoir of T.b. rhodesiense which 
is transmitted to humans from cattle by tsetse fl ies. This north-westwards spread 
of the rhodesiense form of the disease occurred as a result of resettlement and 
restocking of cattle populations which marked the end of civil unrest in the region. 
Sleeping sickness is a human disease whose epidemiology is characterised by 
a tendency for a small number of cases to usher in a massive epidemic. During 
the course of African history such epidemics have depopulated whole areas – 
and Uganda has suffered several outbreaks of this type. Thus, the appearance 
of isolated cases of zoonotic trypanosomiasis in areas where it had never 
before been seen, and the steady progression towards the northwest where 
the gambiense form of the disease is found, needed be treated with extreme 
seriousness.  Diagnosis of the disease is complex, under-reporting considerable 
and the two forms require different treatment. Undertaking differential 
diagnosis and trying to contain an epidemic where the two forms overlapped 
would pose an enormous and expensive medical challenge. 
In order to deal with the situation two main strategies were used:
 • block treating cattle populations to clear the pathogen from   
  the reservoir population, reinforced by treating cattle at markets to  
  prevent reintroduction
 • vector control, with the technique of choice being spraying cattle  
  with an insecticide which was popular with farmers because it  
  controls ticks as well as tsetse fl ies.  
A potential medical emergency 
was averted by a partnership 
involving the Stamp out 
Sleeping Sickness (SOS) 
consortium.
This was composed of the 
Universities of Edinburgh and 
Makerere, IK/IK Aid and Relief 
Enterprise Ltd. (IKARE), CEVA 
Santé Animale, the Ugandan 
Coordinating Offi ce for the 
Control of Trypanosomiasis 
(COCTU) and, since 2010, 
DFID, working with the 
Ugandan Ministry of Health, 
the Ministry of Agriculture 
Animal Industry and Fisheries 
and the implementing districts 
of Uganda. 
 
Anthony Mbonye 
By 2009 the number of new 
human cases had fallen by 
75% and the spread of the 
disease had been halted. 
Data from Ministry of Health, Uganda.
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25 A successful public–private partnership: IKARE and Stamp out Sleeping Sickness in Uganda 
IK Aid and Relief Enterprise Ltd (IKARE) is an independent charity founded in 
2006. Its main sponsor is IK Investment Partners, a leading European private 
equity fi rm. IKARE’s aim is to transfer private equity investment techniques and 
key business concepts into the causes it supports.  Its resources are currently 
fully dedicated to Uganda’s SOS initiative.  This project has been partly 
described in Chapter 24 above.
IKARE’s particular role has been in fi nding a business model for delivering 
the two interventions – treating cattle with trypanocides and spraying them 
with an insecticide to control tsetse and ticks – which have made it possible 
to successfully halt the north-westward spread of zoonotic trypanosomiasis 
in Uganda.  Initially an emergency intervention involving treating 250 000 
cattle was undertaken. Drugs and sprays were donated by CEVA Santé 
Animale. It was then necessary to fi nd a sustainable model which ensured that 
these interventions were taken up and funded by local cattle keepers.  To do 
this, communities comprising some 1.7 million people had to be contacted, 
and made aware of the risks of sleeping sickness to people and of animal 
trypanosomiasis to their livestock, and of the benefi ts that the treatment and 
regular spraying of cattle with insecticide could bring to animal and human 
health.  During this work it became evident that these communities generally 
needed a better supply chain of veterinary drugs and animal health services 
and inputs. 
The solution was to recruit fi ve young graduate veterinarians. Each was 
allocated to an area. They received training in basic business management 
as well as start-up funding.  In addition to supervising and coordinating the 
cattle spraying activities undertaken by farmers and by a network of fi eld spray 
assistants, the veterinarians sell other veterinary products and advise livestock 
keepers and treat their animals.  The SOS distribution network now includes 
80 fi eld spray assistants running their own businesses which have been set 
up with micro-fi nancing. Some 20% of the cattle in the area are now regularly 
treated – a suffi ciently high number to control transmission of sleeping sickness. 
SOS has now been incorporated into the Ugandan Government’s fi ve-year plan 
“Prosperity for All”. 
The three key components in 
SOS’s success have been:
• a sense of urgency
• strong and active partners
• alignment of interest.
Anne Holm Rannaleet
”We have all started and 
legalized our businesses which 
have changed the lives of 
our farmers and ourselves. 
We now feel more relevant 
and have addresses. I have 
particularly liked the whole 
venture because it has kept me 
awake, busy and a lot more 
responsible.”
 Emanuel Isingoma,
SOS Vet
A successful intervention tackling 
a deadly disease of humans by 
controlling the animal reservoir 
and the insect vector.
Delivering veterinary services to the farmers in remote rural areas: Dr Were in front of his newly 
opened shop.
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26 GALVmed: harnessing the private sector to develop vaccines for neglected zoonoses 
A not-for-profi t global alliance of public, private and government partners, the 
Global Alliance for Livestock and Veterinary Medicines (GALVmed) is protecting 
livestock and saving human lives by making livestock vaccines, diagnostics 
and medicines accessible and affordable to the millions for whom livestock is a 
lifeline. With offi ces in the United Kingdom and Africa, GALVmed is currently 
funded by the Bill & Melinda Gates Foundation, DFID and the European 
Commission (the latter through the AU-IBAR – the African Union Interafrican 
Bureau for Animal Resources).
GALVmed’s role is to provide leadership to overcome the challenges to making 
new veterinary products available by creating partnerships which provide poor 
livestock keepers with access to animal health products.
GALVmed began operations in November 2005. Since then, it has played 
an integral role in increasing the resources dedicated to the development of 
diagnostics, vaccines and medicines to tackle livestock diseases. GALVmed 
focuses on 13 key diseases that are most relevant to poverty reduction in 
target areas. These 13 diseases are broken into four categories: avian, swine, 
small ruminant and cattle diseases, although some of them affect more than 
one category. The loss of livestock due to these infections is devastating to the 
existence of their owners, making vaccinations and treatment crucial to the 
economic and physical well-being of the farmers.
Three of the 13 target diseases are NZDs: porcine cysticercosis, Rift Valley fever 
and trypanosomiasis.
For Rift Valley fever, vaccine candidates and a pen-side diagnostic are being 
investigated. The vaccine candidate is a multivalent vaccine with lumpy 
skin disease and sheep and goat pox – which would increase uptake, and 
a monovalent emergency Rift Valley fever vaccine. The pen-side diagnostic 
needs validation according to OIE procedures, after which manufacturing and 
distributing partners will be selected and the assay validated in one country 
before dissemination and distribution begin.
For porcine cysticercosis, the TSOL18 vaccine has been the candidate selected 
(Lightowlers et al. 2003). Agreements have been reached in principle and trials 
are planned to start during 2011. For medication, oxfendazole has been chosen 
as the drug of choice. However, it is currently not registered for pigs at a single 
dose of 30 mg/kg. Pharmokinetic and residue studies are being undertaken 
and animal trials have been fi nalized. It is planned to expand the label claims 
for oxfendazole so as to increase both commercial interest and access by poor 
farmers. Contacts with potential manufacturers have been initiated.
In spite of the crucial link 
between animal health and 
human health, between 
livestock and livelihood, only 
4% of international aid is 
directed to agricultural needs 
in developing countries. And 
only a tiny part of this goes to 
livestock 
 
Johan Vanhemelrijck
Further information can be 
found at:
www.galvmed.org 
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27 WHO’s work at the human–animal health interface 
Understanding, predicting and controlling diseases at the human–animal 
interface is a huge challenge in today’s world, where international trade and 
travel have globalised disease.  WHO is involved at many levels:
 • defi ning policies and sustainable programmes for the prevention  
  and control of priority zoonotic diseases in humans;
 • strengthening early detection, characterization and response to  
  animal related public health risks, including outbreaks;
 • developing international and national capacity, tools and   
  mechanisms for the assessment and reduction of zoonotic diseases  
  associated health risks.
Effective surveillance needs 
to incorporate and react to 
signals from multiple sources 
– thus forecasting Rift Valley 
fever outbreaks in Africa 
would use remote sensing, 
climate and vegetation data.
 Cathy Roth
Surveillance and outbreak prediction are a major component of WHO’s work 
on the human–animal interface. Effective outbreak prediction often depends 
on a multiplicity of signals. A number of networks and associations have been 
set up such as. The Global Early Warning System (GLEWS) which formally 
brings together human and animal health systems to trigger appropriate 
action, provide timely, coordinated, information-driven decision-making 
to avoid or decrease the zoonotic disease burden. A variety of human and 
animal surveillance data and environmental monitoring/detection systems for 
forecasting/prediction is needed to identify potential ‘hotspots’. However, even 
when risks are identifi ed, an adequate underlying infrastructure and resources 
are required to take the measures needed if outbreaks and emergencies are to 
be prevented or controlled.
Collaboration is a prerequisite. This takes place internally across departments, 
clusters and regions at WHO, externally with FAO, OIE, and other international 
agencies, with networks, NGOs, academia, other partners and with national 
agencies, institutions, and ministries. Together FAO, OIE and WHO are 
augmenting their collaboration for promoting a coordinated approach to 
reducing risks of disease transmission at the animal–human–ecosystem 
interface. A strategic agreement outlines the sharing of responsibilities and 
enhanced coordination of complementary roles and activities between  FAO, 
OIE and WHO at national, regional, and global levels.
AGENT
POLITICAL 
FACTORS
INTERVENTIONS
ENVIRONMENTHOST
ECONOMIC FACTORS
SOCIAL FACTORS
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28 Renewed emphasis at TDR on neglected zoonotic diseases in tropical diseases research 
TDR – the UNDP/UNICEF/World Bank/WHO Special Programme for Research 
and Training in Tropical Diseases has recently produced its new research 
strategy, which incorporates a renewed emphasis on zoonotic diseases. The 
objectives to be delivered fall under three headings.
 1. Stewardship: for research on infectious diseases of poor   
  populations through harmonized global research efforts;
 2. Empowerment: of researchers and public health professionals  
  from disease endemic countries with research leadership in those  
  countries;
 3. Innovation: enhanced access to superior interventions – including  
  strengthening of health services.
The concept of stewardship for research on infectious diseases of poverty aims 
to coordinate and harmonize research efforts. It hopes to achieve a coherence 
of priorities, agenda and support as well as collaboration among stakeholders, 
so that research works effectively in creating “options for action” against 
diseases of poverty. Equitable access to research information underlies this 
strategy, with the objective of ensuring that enhanced resources are allocated 
to research on the diseases of poverty, that this work is supported by the 
governments of disease endemic countries and, ultimately, that these countries 
make use of the research outputs.
TDR is using a think tank approach to defi ning what the research needs and 
priorities are within each topic. Each think tank is supported by a reference 
group. The NZDs have their own reference group consisting of seventeen scientists 
representing all WHO regions.  The areas of core expertise which need covering 
for the NZDs are veterinary public health, veterinary laboratory science, wildlife 
biology, epidemiology/public health, social sciences (medical anthropology), 
community medicine and health (geography), clinical medicine (infectious 
diseases), parasitology/microbiology/genomics and genetics (laboratory), health/
agriculture/livestock economics, water/sanitation and diagnostics.
The table below shows how for a series of epidemiological research components 
the rankings might be prioritized for some zoonotic diseases, including NZDs – 
it is intended as an example, not a defi nitive analysis. 
For NZD research the three top 
priority areas are:
 • estimating the burden of 
  zoonotic diseases going  
  beyond DALYs to include  
  monetary losses to humans  
  and animals, nutritional  
  impacts (milk, meat losses),  
  manure and cash assets;
 • assessing the cost
  effectiveness of health- 
  care delivery methods 
  for the control of zoonoses  
  and marginalised
  infectious diseases of 
  poverty at community   
  level;
 • promoting intersectoral  
  collaboration (health,   
  livestock, agriculture,
  natural resources and  
  wildlife), cross systems  
  policy and prioritization.
 
Ayoade Oduola
For further information visit 
TROpIKA, a “one-stop shop 
for knowledge sharing” at 
www.TropIKA.net 
or read about the Global 
Report on Research for 
Infectious Diseases of Poverty 
http://apps.who.int/tdr/svc/
news-events/news/global-
report
Research components  Cysticercosis Echinococcosis  Rabies Brucellosis Toxoplasmosis Schistosomiasis Foodborne 
 /taeniasis     japonica  trematodes
Burden of disease in ++++ +++ ++ +++++ +++ +++ ++++
humans and animals
Innovations in ++++ ++++ +++ +++ +++ ++++ ++++
surveillance
Prevalence mapping +++ +++  +++  +++ +++
and spatial analyses
Risk factor analyses ++ +++    +++ +++
Evaluation of +++ ++++ ++ +++++ ++ ++++ +++
interventions
Contribution to non- +++++ ++ + +++ +++ ++ +++++
communicable conditions
Transmission ++++ ++++ + +++++ + ++++ +++++
dynamics models
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29 ICONZ: 21 partners dedicated to improving control of neglected zoonoses in Africa
In April 2009, a large multi-centre research project was launched in Edinburgh, 
funded by the EU under its Framework 7 (FP7) programme. ICONZ “Integrated 
Control of Neglected Zoonoses in Africa” was largely inspired by the 1st and 
2nd Neglected Zoonotic Diseases meetings held in Geneva and Nairobi. The 
ethos of these meetings informed both our objectives and choice of diseases.  
ICONZ is researching eight neglected zoonoses, grouped into four clusters, so 
that added value can be gained from combining control and research activities: 
 • bacterial zoonoses (anthrax, brucellosis and bovine TB)
 • dog/small ruminant (rabies, cystic echinococcosis and leishmaniasis)
 • pig-associated diseases (T. Solium cysticercosis/taeniosis)
 • vector-borne diseases (zoonotic trypanosomiasis, with spill-over  
  effects from vector control onto malaria in people and tick-borne  
  diseases in cattle). 
ICONZ has study sites in Mali, Morocco, Mozambique, Nigeria, Uganda, the 
United Republic of Tanzania and Zambia. Its partners are leading research 
institutes working on zoonoses in each of these countries and European 
institutes with expertise in diagnostics, disease control tools and applied 
epidemiology. Its activities include:
 • creating an inventory of and mapping global research on the NZDs,
  with a view to collating existing knowledge and identifying gaps 
 • reviewing existing tools for diagnosing and controlling these  
  diseases and identify areas for improvement
 • updating knowledge of and further investigating these diseases’  
  burden in people and their costs to livestock production. 
Central to ICONZ’s work are fi eld-based case studies in Africa which will consist 
of three phases:  
 • an investigation of disease prevalence in livestock, linked as much  
  as possible with work being done on the disease in people;
 • baseline surveys on relevant livestock productivity indicators and  
  on people’s knowledge, attitudes and practice to the diseases under  
  study;
 • the trial of an intervention in the study areas, followed by   
  assessing impact and cost with a view to demonstrating cost- 
  effectiveness.
In the fi eld a key role in the case study research is being played by students – 
and capacity building at all levels is an important component of ICONZ.  The 
fi nal phases of ICONZ will focus more on public engagement – investigating how 
the disease control strategies can be better integrated into the work of existing 
medical and veterinary health services and on infl uencing policy makers. 
As we reach out to
marginalized populations, 
public engagement
with all stakeholders is 
essential for ensuring
that culturally appropriate 
measures for dealing with 
these diseases are adopted 
into the policy frameworks of 
all affected countries. 
 Sue Welburn 
Further information can be 
found at:
http://iconzafrica.com/ 
Working in Nigeria investigating 
brucellosis in a pastoralist 
community
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30 Research on neglected zoonotic and infectious diseases supported by the European Union  
The successive European Union Framework Programmes for Research and 
Technological Development have supported research into diseases classifi ed as 
“Neglected Infectious Diseases” and “Neglected Zoonotic Diseases”. Information 
is provided on the ongoing projects supported by the EU 7th framework 
programme for research 2007–2013 (FP7) in the “Health” and “Food, 
Agriculture and Fisheries and Biotechnologies” themes. 
In the “Health” theme there are four areas of research into infectious diseases 
in humans: 
 • poverty-related diseases (HIV/AIDS, malaria, TB);
 • anti-microbial drug resistance;
 • potentially new and re-emerging epidemics: viral diseases ;
 • neglected infectious diseases (NIDs): helminth, bacterial and  
  protozoal diseases.
Among the NIDs, the priority diseases targeted are: helminth diseases 
(lymphatic fi lariasis, schistosomiasis, ascariasis, trichuriasis, hookworm), 
protozoal diseases (trypanosomiasis, leishmaniasis, Chagas disease) and 
bacterial diseases (Buruli ulcer, leprosy, trachoma and infantile diarrhoea). 
These projects aim to contribute to the long-term control of NIDs and include 
(i) transnational research for drug and vaccine development and (ii) research 
on disease control including diagnostics, vector control and health systems 
research. 
In the “Food, Agriculture and Fisheries and Biotechnologies” theme neglected 
zoonoses are included as a priority under animal health research. The most 
relevant project is ICONZ (see Chapter 29). In the call for 2011, a topic has 
been included on focusing training programmes for researchers working on 
NZDs in order to “create a culture of collaboration” between the animal and 
human health sectors. Other EU projects are targeted at improving the tools 
and knowledge of specifi c diseases of livestock present in the developed and 
developing countries such as bovine tuberculosis (TB-STEP) and helminth 
infections (PARAVAC) which addresses fascioliasis and echinococcosis, among 
others.
There is a number of other EU projects of great relevance to the control of 
NZDs. One such project is DISCONTOOLS, which emanates from the European 
Technology Platform for Global Animal Health (ETPGAH).  It has provided a 
mechanism for focusing and prioritising research that ultimately will deliver 
new and improved vaccines, pharmaceuticals and diagnostic tests, based on 
gap analyses of 49 diseases, of which 10 are NZDs. The European Commission 
strongly supports coordination of research funders at both the European and 
international level. Another such project is MED-VET-NET, where successful 
collaboration has been established between animal health and human health 
research, mainly on foodborne diseases.
Efforts should continue to 
ensure a multidisciplinary 
approach. Socio-economic, 
cultural/religious and 
anthropological aspects 
are key disciplines for the 
successful control of NZDs. 
To these must be added the 
active involvement of local 
communities. The cutting edge 
“omics” research alone is not 
enough. 
International organizations 
and other key players should 
make efforts to unite forces 
beyond traditional political 
groupings to benefi t the most 
impoverished populations of 
the planet who are the major 
sufferers from these diseases.
 
Isabel Minguez-Tudela
The work under FP7 can be 
accessed at: http://cordis.
europa.eu/fp7/home_en.html
To fi nd out more about the 
work on NIDs visit: http://
ec.europa.eu/research/health/
infectious-diseases/neglected-
diseases/index_en.html
Information about 
DISCONTOOLS can be found 
at http://www.discontools.eu/
home/index 
and about ETPGAH on http://
www.etpgah.eu/
MED-VET-NET is described 
at http://www.medvetnet.org/
cms/
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Neglected zoonotic diseases in the broader 
picture of agriculture and human health:  
the CGIAR’s vision
In late 2008, a major change process for the Consultative Group for 
International Agricultural Research (CGIAR) was initiated. The purpose was to 
provide more coordination between researchers by bringing the 15 individual 
research institutions together in a legally constituted consortium and in aligning 
its more than 60 funders in a Fund Council to support longer-term and larger 
research programs with greater focus on development outcomes and impacts.
As part of this change, larger research programmes are being formulated. 
Some of these relate to the traditional strengths of the CGIAR in enhancing 
agricultural productivity. Others are responding to evolving challenges such 
as water scarcity, land and forest degradation and climate change. One new 
programme which specifi cally incorporates NZDs is called: “Agriculture for 
improved nutrition and health”. This programme focuses on how agri-food 
systems can be shaped to promote better human nutrition and health outcomes. 
The basic concept driving the 
CGIAR research programme 
“Agriculture for improved 
nutrition and health” is the 
idea that agriculture practices 
and interventions can be 
adapted to maximize health 
and nutrition benefi ts and 
reduce health risks.
With respect to the NZDs 
research will focus on:
 • better quantifi cation of the
  multiple burdens of  
  neglected zoonoses and  
  benefi ts of their control;
 • research into evolving  
  zoonotic disease risks as
  agricultural systems   
  intensify;
 • improving control 
  strategies and how they  
  can be delivered within a
  broader development   
  agenda. 
 John McDermott
Overall, the CGIAR research contributions to agricultural development are 
designed to improve food security, reduce poverty, and improve environmental 
sustainability and these development impacts are directly linked to health and 
nutrition impacts. An important goal of this programme is to bring a health and 
nutrition focus to the overall CGIAR, to inform partners’ efforts to better shape 
agri-food systems so as to maximize development impacts.
Shaping future agri-food systems will involve addressing trade-offs between 
maximizing different agricultural benefi ts and minimizing risks. This 
programme will provide evidence and intervention options for managing 
these trade-offs from a health and nutrition perspective, targeting two specifi c 
populations: (i) marginal and vulnerable populations and (ii) populations 
affected by agricultural intensifi cation.
FOOD SECURITY
IMPROVED AGRICULTURE
ENVIRONMENTAL SUSTAINABILITYPOVERTY REDUCTION
CGIAR DEVELOPMENT OUTCOMES
HEALTHNUTRITION
Incomes 
Employment
Dietary quality
Gender Equity
Water-related diseases
Foodborne diseases
Zoonotic diseases
Occupational hazards
Emerging diseases
MAXIMAZING BENEFITS REDUCING RISKS
TARGET POPULATIONS
Vulnerable and marginal populations
Populations exposed to agriculture intensifi cation
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32 OIE’s commitment to dealing with neglected zoonotic diseases
All the seven major diseases in WHO’s initial list of NZDs are OIE listed 
diseases. Anthrax, rabies, and cystic echinococcosis are notifi able to the OIE 
for multiple different animal species, while bovine tuberculosis, brucellosis, 
cysticercosis and African trypanosomiasis are listed diseases for selected 
species, for example in bovines or in swine. This means that for each of these 
diseases, the OIE provides Members and the broader veterinary community 
with science-based guidance on their detection, surveillance and control, 
including international standards related to the safety of trade in animals and 
animal products.
Two key components of OIE’s activities are of particular relevance in the 
fi ght against neglected zoonoses. Due to the hard work of national Veterinary 
Services (VS), we have seen much success in the control of certain animal 
diseases in different regions; however, many endemic animal diseases 
continue to be present, requiring that we do not lower our vigilance. The OIE 
has produced guidelines for the evaluation of the Performance of Veterinary 
Services – the PVS tool – which aims to promote and facilitate good governance 
within veterinary services.
In the case of zoonotic diseases, the efforts of the national VS should clearly be 
carried out in strong collaboration with public health partners. PVS missions 
follow a pathway towards achieving effi cient VS:
 • evaluation, or “diagnostic” phase
 • gap analysis or “prescription”
 • selected interventions or “treatment”, which may include a  
  strategic plan, modernising legislation, public–private   
  partnerships, country/donor investments/projects, veterinary  
  education and laboratories.
A second key element is diagnostics – already identifi ed as an important 
bottleneck for effective NZD control. There are 190 OIE reference laboratories 
in 36 member countries or territories, providing expertise on 100 OIE listed 
diseases. In addition there are 37 collaborating centres from 20 member 
countries or territories which provide expertise in a specifi c designated sphere 
of competence such as epidemiology or risk analysis.  
Finally, OIE is involved in a number of rabies related activities  
Veterinary Services (VS), in 
fulfi lling their veterinary 
public health responsibilities, 
are a critical component in the 
control of these diseases, for 
the benefi t of both animal and 
human health. A competent VS 
functioning under a system of 
good governance is a Global 
Public Good.
 
Kathleen Glynn
Twinning provides a link 
between an OIE reference 
laboratory or collaborating 
centre and a national 
laboratory wishing to improve 
capacity and expertise for an 
OIE listed disease or sphere 
of competence.
The OIE’s rabies information 
including guidelines are 
available online in English, 
French and Spanish
http://www.oie.int/eng/info_
ev/en_Rabies_Control.htm
http://www.oie.int/fr/info_ev/
fr_Rabies_Control.htm
http://www.oie.int/esp/info_
ev/es_Rabies_Control.htm
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33 Veterinary public health and neglected zoonotic diseases at FAO
The Animal Production and Health Division at the Food and Agriculture 
Organization hosts the Animal Health Service. In 1999 the position of an 
Animal Health Offi cer dedicated to Veterinary Public Health was created within 
the Parasitic Diseases Group. Another position on bacterial diseases within 
the Infectious Diseases Group addressed brucellosis and anthrax alongside a 
number of other bacterial animal diseases. With the rise of highly pathogenic 
avian infl uenza (HPAI/H5N1) in 2003, the importance of especially addressing 
emerging zoonotic diseases was recognized globally. Unprecedented resources 
were mobilized for a zoonotic disease with potential pandemic spread. 
Furthermore, the need to address diseases in animal populations before they 
impact human health was recognized and the establishment of inter-ministerial 
committees and task forces in many countries enabled the coordination of the 
different sectors primarily involved in addressing HPAI/H5N1. In addition to 
animal and human health, sectors dealing with wildlife, emergency procedures 
and fi nances were brought to the table.
As this group of diseases 
is closely linked to poverty 
and the lack of access to 
information, services and 
resources, FAO is committed 
to address these diseases 
through fostering development, 
income generation and 
protecting peoples’ livelihoods 
and food security. 
How can services and 
interventions be delivered in 
poor and marginalized areas? 
How can public awareness 
be enhanced and acceptable, 
practicable and cost-effective 
interventions be found? 
The rapid rise of new 
technologies such as mobile 
phones and internet access 
provides unprecedented 
opportunities in developing 
countries.
 
 Katinka de Balogh
The FAO approach to zoonotic diseases has followed the typology illustrated in 
the fi gure. Each group of diseases requires a different approach.
 • For the neglected zoonoses, better health systems, development  
  and poverty alleviation measures and public awareness are   
  needed.
 • For the emerging zoonoses, emergency preparedness, early  
  detection and rapid responses are essential. 
 • For the foodborne diseases, control is via the food chain, consumer  
  empowerment and certifi cation. 
Some NZDs fall into several categories. Thus anthrax and brucellosis fi t into 
all three. Cysticercosis and bovine TB are also foodborne, and rabies, RVF and 
leishmaniasis are also emerging zoonoses in some areas.
Many of the lessons learned from HPAI/H5N1 can also be used for addressing 
other zoonoses. The importance of good surveillance systems and laboratory 
facilities for early detection as well as functioning services that will be able to 
rapidly respond to any new event have been recognized. Nevertheless while 
much attention and funding is directed in detecting unusual events, there 
continues to be the need to engage in fi nding better prevention and control 
strategies to address the neglected zoonoses.
NEGLECTED 
ZOONOTIC 
DISEASES
EMERGING 
ZOONOTIC 
DISEASES
FOODBORNE 
ZOONOTIC 
DISEASES
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From the global response to infl uenzas 
towards One Health: initiatives of the 
European Commission
The European Commission and the European Union as a whole have been 
a major global actor in the response to the infl uenzas crises, both politically 
and fi nancially, linking crisis prevention and response to long-term capacity 
building and improvement of livelihoods. The One Health movement has in 
many senses grown out of the response to these crises. The defi nition of One 
Health chosen by the European Commission in its external relations and actions 
reads as follows: the One Health approach consists of (i) improving health and 
well-being through the prevention of risks and the mitigation of the effects 
of crises that originate at the interface between humans, animals and their 
various environments; (ii) for that purpose: a) promoting a multi (cross) sectoral 
and collaborative approach; and b) promoting a “whole of society” approach to 
health hazards, as a systemic change of perspective in the management of risk.
At the international ministerial conferences on avian/animal and pandemic 
infl uenza (IMCAPI) of New Delhi, Sharm-El-Sheikh (2008) and Hanoi (2010), the 
European Commission made declarations at the international level in support 
to the One Health approach in its external relations policies. Those statements 
include the following key political points of relevance in the battle to control 
NZDs:
 • One Health is linked to livelihood and equity: there should be no  
  resignation vis-à-vis the existence of different health standards  
  across nations.
 • One Health fi ts with EU objectives: to promote global security,  
  social justice, international cooperation, multilateralism and fi ght  
  poverty.
Neglected zoonotic diseases are by defi nition an important topic covered by 
the One Health approach. The Commission believes that the criteria to address 
them specifi cally in projects and programmes will largely depend upon the 
appropriate advocacy by technical agencies that should be based on cost/benefi t 
analyses. Those analyses should also address the political cost of “no action”. 
Finally, the current One Health regional action programme in Asia (2009-2012) 
on Highly Pathogenic Emerging or re-emerging Diseases (HPED) is not limited 
to any given disease. Should ASEAN, SAARC or their member countries wish to 
include one or more NZDs, this can easily be done. The agencies responsible for 
such actions are OIE, FAO and WHO as implementing agencies, together with 
the ASEAN and SAARC secretariats and the national authorities covering public 
and animal health, as leaders of the programme.
On the ground, there is a need for systematic collaboration between strong 
and autonomous public health services and strong and autonomous veterinary 
services, in the respect of their specifi c expertises. The One Health initiatives 
that have followed the avian infl uenza crisis have seen the strengthening of 
laboratory capacity and the creation of joint medical/veterinary fi eld teams. 
In Asia there are currently more active and ongoing human–animal health 
programmes than there have ever been. But a culture of cross-sectoral 
collaboration does not yet exist all along the chain. Fostering such a culture 
stretching from the fi eld level to that of international organisations is the big 
challenge for successfully controlling either emerging or neglected zoonotic 
diseases.
The post avian infl uenza 
context and ‘One Health’ 
concept provide a window 
of opportunity to streamline 
the prevention and control of 
NZDs.
 
Alain Vandersmissen
‘One Health’ is a fi rst step 
towards improving health 
outcomes incorporating 
human and animal health 
policies in all relevant sectors
 
Hanoi Declaration 
April 2010.
The Control of Neglected Zoonotic Diseases
46
35 Implementing ‘One Health’: follow-up from the Stone Mountain Meeting
Following the Winnipeg consultation in 2009, a meeting was organized by the 
Centers for Disease Control and Prevention (CDC) in collaboration with FAO, 
OIE, WHO, to move the concept of One Health forward, and to defi ne specifi c 
action steps. The meeting was hosted by the CDC, Atlanta, Georgia in May 2010 
and was titled: Operationalizing One Health: a policy perspective – taking stock 
and shaping an implementation roadmap.
Fifty-four participants including specialists from national Ministries of Health and 
Agriculture, the European Commission, the UN, the World Bank, and other diverse 
institutions from the academic, policy and economic sectors contributed their 
expertise and experience to the discussion. The group reviewed progress to date in 
terms of leading practices related to One Health and identifi ed key policy decisions 
and fi nancial commitments necessary to support sustainability and expansion.
The participants were then asked to discuss a vision of how One Health should 
appear globally in the next 3–5 years. The following points were identifi ed and 
agreed upon, for a common vision of One Health.
Our specifi c goal:
to develop sustainable 
intersectoral collaboration 
at international, regional 
national, and sub-national 
levels by identifying concrete 
opportunities for implementing 
‘One Health’ strategies and   
recognizing key barriers 
and possible options for 
overcoming these barriers. 
 
 Malika Kachani
Updates will be available at 
CDC One Health website: 
www.cdc.gov/onehealth
The participants were then asked to identify “critical enabling initiatives” 
that will further attainment of the 3–5 year goals, and that are feasible for 
completion over the next 18 months. Seven key activities were selected as 
fundamental to moving forward under the One Health agenda. 
 1. Training: develop and build skills, expertise and competencies  
  through a One Health training curriculum which could be   
  integrated into existing curricula.
 2. One Health Global Network: establish a network as a vehicle for  
  further global collaboration, advocacy and international support  
  mobilization on One Health programmes and projects.
 3. Information Clearing House: promote One Health advocacy  
  through a centralized area where One Health success stories are  
  gathered and made available to a wide-ranging audience.   
 4. Needs Assessment: develop country level self-assessment methods  
  to identify programmatic areas that could benefi t from a One  
  Health approach and areas for targeting improvement.
 5. Capacity Building: identify ways to leverage existing programs  
  and capacity-building efforts in order to have a major impact at  
  limited cost. 
 6. Proof of Concept: demonstrate that the use of One Health   
  interventions leads to better cross-species health outcomes. 
 7. Business Plan: articulate the subject area of One Health more clearly  
  and present it to policy-makers and donors at the global level.
A culture change that appreciates the importance of the connection between 
humans, animals and ecosystems.
An increased visibility that recognizes the value added by operationalizing 
the One Health approach in preventing, detecting and controlling diseases that 
impact both humans and animals
Designated funding to support interdisciplinary collaborative programs.
An improved coordination that includes intersectoral collaboration in 
surveillance, communications, outbreak response and sample sharing
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36 Concluding statement: developing a roadmap for NZD prevention and control
The theme of the third international conference on NZDs – community-based 
interventions – considered the involvement and contribution of communities, 
often supported by government services and nongovernmental organizations, 
in the prevention and control of NZDs. A number of countries’ successes 
in preventing and controlling NZDs were presented, including zoonotic 
trypanosomiasis (Uganda), rabies (China, Peru, the Philippines and Sierra 
Leone), fascioliasis (Peru and Viet Nam), echinococcosis (China), cysticercosis 
(Zambia), as well as issues of epidemic-prone NZDs such a Rift Valley fever 
(horn of Africa) and leptospirosis.
The Consultation issued a statement on the way forward to promote progress in 
combating NZDs
The third international 
consultation on neglected 
zoonotic diseases
Over 100 people from all 
6 WHO regions took part, 
meeting in the WHO executive 
boardroom in Geneva.
Those attending included 
individuals involved in active 
disease control programmes, 
research, policy-making 
and representatives of 
international organisations, 
NGOs as well as private sector 
companies who have funded 
NZD control work.
Together we produced the 
following statement.
THE CONSULTATION – ACKNOWLEDGING
1.1 The considerable progress that has been made since the fi rst (2005) and 
second (2007) international conferences on NZDs (see Chapter 2: Five years on 
– taking stock).
1.2 The high rates of both under-reporting and misdiagnosis (clinical and 
laboratory-based) for NZDs in communities of poor and marginalized peoples 
and the substantial global burden these diseases impose on such communities 
especially in rural areas traditionally dependent on livestock for food, transport 
and draught power.
1.3 The name “neglected zoonotic diseases”, or “NZDs” for this group of 
diseases emphasizes a new approach to dealing with them. This terminology 
acknowledges that these diseases are not well addressed and recognizes that 
three key requirements should be met for successful prevention and control 
of NZDs: (i) that consideration be given to both the needs of communities 
and their livestock and to companion animals affected by NZDs; (ii) that 
integrated approaches be available to cure, prevent and control disease at the 
human–animal interface; and (iii) that evidence-based advocacy be used to 
lever resources and commitment for control from the national and international 
community.
The meeting was opened by Lorenzo Savioli, Director NTD and convened by François Meslin, 
Team Leader NZD.
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1.4 NZDs as a heterogeneous group of diseases which is best defi ned by the 
people and communities they mostly affect. As such, the list of NZDs is open-
ended and depends on location; as well as endemic diseases, it may comprise 
epidemic-prone diseases such as leptospirosis, anthrax and Rift Valley fever.
1.5 The One Health approach, which addresses the actions required to 
alleviate the suffering and losses caused by NZDs at the human–animal 
interface. Control activities need to cover people, animals and their 
environments, and veterinary and human medical sectors need to work 
collectively to ensure successful control of NZDs. Where feasible, emphasis may 
be placed on controlling the animal reservoirs, and activities implemented in 
close collaboration with key sectors involved.
1.6 The cost-effectiveness of controlling these diseases can reap a dual 
harvest in saving human lives and securing livelihoods by protecting livestock 
and other domestic animals, which in turn contributes to alleviating poverty 
within affected communities.
1.7 The feasibility of preventing, controlling and possibly eliminating those 
NZDs for which effective and workable proven solutions are available 
(for example, dog-mediated human rabies and zoonotic trypanosomiasis) or 
that are within sight and for which control packages will be available or “tool 
ready” within 3–5 years of conducting implementation research (for example, 
cysticercosis, cystic echinococcosis and foodborne trematode infections).
 
THE CONSULTATION – CONSIDERING
2.1 The universally low ranking of NZDs on national and international 
health agendas despite their causing signifi cant morbidity and mortality in 
the impoverished, mostly rural, livestock-dependent communities in which 
they exist. NZDs usually do not cross international borders and rarely affect 
international trade or travellers (unlike the new emerging zoonotic diseases 
such as avian infl uenza or SARS [severe acute respiratory syndrome]).
2.2 The challenges of scaling up implementation of control approaches using 
known strategies, testing the feasibility and cost-effectiveness of those strategies 
and in parallel prioritizing control of NZDs on the research agenda.
2.3 The lack of investment in prevention and control activities and 
of applied research on NZDs from development aid and assistance 
programmes within developed countries and from other sources of health 
funding at a time when expertise in developed and developing countries and 
funding for capacity strengthening in developing countries are waning. It 
is estimated that only 0.06% of international global assistance for health is 
devoted to the control of NZDs.
2.4 The lack of veterinary public health (VPH) units bridging the gap between 
departments of agriculture and health and that of competent practitioners in 
human health and veterinary services to serve the needs of communities in 
developing countries in addressing NZDs.
2.5 The need to identify and mobilize, in those countries most affected by 
NZDs, internal and external funding sources to facilitate capacity-building for 
human and animal health staff in all aspects of surveillance, prevention and 
control of NZDs.
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THE CONSULTATION – RECOMMENDS THE CREATION OF A ROAD MAP TO 
PROMOTE PROGRESS IN COMBATING NZDS WHERE THEY ARE MOST PREVALENT 
THAT INVOLVES
3.1 Developing a comprehensive methodology for measuring the burden 
of disease that is attributable to zoonotic infections, providing the evidence-
base required for needs assessment and advocacy; and assessing within this 
methodology the local, regional and global societal burdens of NZDs in fi nancial 
and non-fi nancial terms, thus defi ning the priority diseases for control on a 
local and regional basis.
3.2 Conducting further studies to determine the costs of intervention 
strategies, cost-benefi ts and cost effectiveness. In addition to measuring the 
direct and indirect medical costs and benefi ts, such studies should also consider 
the economic and societal impacts of animal disease as indirect contributors to 
poverty through their impact on nutrition, loss of meat and milk products, and 
the effects on livestock as capital assets.
3.3 Scaling-up interventions for control of NZDs in selected geographical and 
epidemiological settings using existing innovations and research outputs that 
are not being used for reasons of cost, lack of policy, intersectoral collaboration, 
commitment of relevant government structure and awareness, together with 
insuffi cient understanding of the high value offered by interventions that 
simultaneously target animals and reduce the disease burden in humans. Such 
activities should be based on the following four principles.
 3.3.1 Strengthening or consolidating intersectoral collaboration,
  communication and interaction using operational research and  
  systems among key health, agricultural and environment sectors. This  
  principle requires that guidelines on how to establish, structure and 
  sustain VPH units be established at the national level. The   
  contribution of VPH units to public health care should be clarifi ed,  
  while recognizing that the responsibilities of these units go beyond  
  control of NZDs. Competent human and animal health services are a  
  public good, and maintaining qualifi ed VPH workers close to their  
  communities should be considered an essential governmental   
  responsibility. National intersectoral committees on zoonoses working  
  under ministerial or a higher authority should be established or  
  strengthened.
 3.3.2  Controlling animal reservoirs as the most effective approach to  
  combating any animal disease, including most NZDs. This principle  
  relies on a pool of VPH specialists working under a system of good  
  governance. In many countries, such efforts should be carried out  
  jointly by competent national VPH and public health services with  
  the help and support of local and regional authorities applying the  
  One Health approach. 
 3.3.3  Adopting or combining multi-disease and host approaches for  
  selected NZDs in their animal reservoirs. This principle relies on 
  effective governmental services and the contribution of other   
  stakeholders, principally communities affected by NZDs, and NGOs  
  to improve animal and public health and, in parallel, ensuring   
  environmental sanitation and providing the necessary health-care  
  education and promotion to those communities involved.
 3.3.4  Community-based approaches and interventions developed   
  to control specifi c diseases such as zoonotic trypanosomiasis, rabies  
  and foodborne trematode infections should be evaluated for their  
  applicability to other NZDs. Disease-specifi c and government-  
  supported interventions may still represent a viable alternative under  
  certain circumstances.
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3.4 Initiating priority studies on short-term and longer-term packages of 
research to improve and sustain control of NZDs at scale. Stated priorities 
are grouped as disease-specifi c or intervention-specifi c (environmental health, 
intersectoral collaboration, epidemiological studies); these priorities relate 
to health education, health promotion and improved understanding of the 
environmental and social ecology of NZDs and their impact on both livestock 
production and local economies. 
3.5 Strengthening advocacy within constituencies for NZDs to better inform 
all stakeholders, including funding agencies, about the societal burden of these 
diseases to create demand for control at all levels of society.
3.6.Providing resources to implement specialized training in all aspects 
of surveillance, prevention and control to serve national human health and 
national veterinary services in countries where NZDs represent a signifi cant 
threat to local communities. Training in surveillance and laboratory diagnosis 
of NZDs is of paramount importance to improve reporting and assess their 
burden.
3.7.Providing affected countries with the skills to develop economically 
sustainable national control strategies, including economic evaluations 
integrating cross-sectoral costs and benefi ts.
3.8 Identifying priority NZDs in each WHO region and country by 
considering their impact on both human and animal health and the level of 
commitment for prevention and control from interested sectors. This approach 
will require budget lines from the relevant implementing ministries as well as 
national research commitments, stable policy and essential long-term national 
and international fi nancing.
3.9 Requesting the WHO Secretariat, in collaboration with its partners and 
other stakeholders, to help defi ne priorities and achievable goals and set 
targets and indicators to monitor the state of implementation of this road-map 
in 2 years’ time. An inventory of the current and potential funding landscape 
for NZDs and an evaluation of their cumulative burden as well as a critical 
review of the outcomes of previous meetings would be useful.
3.10.Requesting pharmaceutical companies to broaden the scope of their 
collaboration and funding to include pharmaceutical products and the 
development of vaccines to be used in the context of interventions against 
NZDs.
3.11 Increasing awareness among the international funding community of 
the local, regional and global impacts of NZDs, and urging funding agencies 
to consider NZDs as an integral part of their portfolios in order to assist 
governments in supporting affected communities.
Listening and discussing during the meeting .
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Abbreviations
AE .........................alveolar echinococcosis
AIDS .....................acquired immunodefi ciency syndrome
ASEAN ..................Association of South East Asian Nations
BMGF ....................Bill & Melinda Gates Foundation
CDC .......................Centers for Disease Control and Prevention (USA)
CE .........................cystic echinococcosis
CGIAR ...................Consultative Group on International Agricultural Research 
CLTS .....................community-led total sanitation
COCTU ..................Coordinating Offi ce for the Control of Trypanosomiasis
 (Uganda)
DALY .....................disability-adjusted life year (measure of health burden
 in humans)
DANIDA ................Danish International Development Agency
DFID .....................Department for International Development (UK)
EU .........................European Union
FAO .......................Food and Agriculture Organization of the United Nations
FERG ....................Foodborne Disease Burden Epidemiology Reference Group
 (WHO)
FOS .......................Food Safety and Zoonoses (WHO)
GALVmed..............Global Alliance for Livestock and Veterinary Medicines
GARC ....................Global Alliance for Rabies Control
GBD ......................global burden of disease 
HAT ......................human African trypanosomiasis
HIV .......................human immunodefi ciency virus`
HPED ....................highly pathogenic emerging or re-emerging diseases 
HSE .......................Health Security and Environment (WHO)
HTM......................HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical
 Diseases (WHO)
ICONZ ...................Integrated Control of Neglected Zoonoses 
IEC ........................information, education and communication
IKARE ...................IK Aid and Relief Enterprise Limited 
ILRI.......................International Livestock Research Institute
LERG ....................Leptospirosis Burden Epidemiology Reference Group
MDG......................millennium development goal
NCC .......................neurocysticercosis
NGO ......................non-governmental organization
NID .......................Neglected infectious diseases
NIH .......................National Institutes of Health
NIMPE ..................National Institute of Malariology, Parasitology and
 Entomology (Viet Nam)
NTD ......................neglected tropical diseases
NZDs .....................neglected zoonotic diseases
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OD .........................open defecation (see CLTS)
OIE ........................World Organization for Animal Health 
PAHO ....................Pan American Health Organization
PEP .......................post-exposure prophylaxis (rabies)
PVS .......................performance of veterinary services 
Rabnet ..................Rabies network (WHO database on rabies)
RiU........................Research Into Use (DFID)
RVF .......................Rift Valley fever
SAARC ..................South Asian Association for Regional Cooperation
SADC  ...................Southern African Development Community
SOS  ......................Stamp out Sleeping Sickness (Uganda)
SEARG ..................Southern and Eastern African Rabies Group
TB .........................tuberculosis
TDR ......................Special Programme for Research and Training in Tropical
 Diseases (UNDP/UNICEF/World Bank/WHO)
UNDP ....................United Nations Development Programme
UNICEF .................United Nations Children’s Fund 
VLIR .....................Vlaamse Interuniversitaire Raad (Belgium)
VPH ......................veterinary public health
VS .........................veterinary services 
WAHID ..................World Animal Health Information Database (OIE)
WHO .....................World Health Organization 
WRD .....................World Rabies Day
YLD .......................equivalent years (of healthy life) lost due to disability
YLL .......................years of life lost
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